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DISSERTATION ABSTRACT 
Mark W. Reid 
Doctor of Philosophy 
Department of Psychology 
March 2014 
Title: Gene-Environment Interactions in Cortisol Reactivity: Sex, Genes, and Adversity 
Predict Responses to Psychosocial Stress 
 
 
Extreme variations in cortisol reactivity are associated with multiple 
psychological and physiological diseases. These variations may be explained by sex, by 
genetic vulnerabilities, and by exposure to either recent life stressors (severe life events 
or ongoing difficulties) or early life adversity (e.g., antipathy; neglect; or psychological, 
physical, or sexual abuse). To explore interactions among these variables, a subset of 20-
22 years-old individuals (N = 373) recruited for an ongoing longitudinal cohort-
sequential study of substance abuse risk factors were assessed. These individuals were 
interviewed about early childhood abuse and recent stressful life experiences. They were 
also genotyped for multiple polymorphisms within genes associated with attenuated or 
exaggerated cortisol reactivity (5-HTTLPR and rs25532 in SERT, rs4680 in COMT, 
rs5522 in MR gene NR3C2, rs110402 and rs1876831 in CRHR1, rs1799971 in OPRM1, 
and rs1800497 in ANKK1), participated in a laboratory social stress task, and provided 
salivary cortisol samples throughout the task. Results indicate that cortisol reactivity may 
be shaped by both early and recent life experiences and genetic vulnerabilities; most 
interactions between these variables differed depending on an individual’s sex.  
Specifically, carriers of two copies of minor alleles of ANKK1, COMT, and CRHR1 
v 
displayed dysregulated cortisol that varied according to sex and early life experiences. 
Male minor allele carriers who experienced more severe physical abuse displayed 
attenuated reactivity, and males who were not severely abused displayed exaggerated 
responses. Female minor allele carriers displayed the opposite pattern – abused females 
displayed exaggerated reactivity. Carriers of major alleles did not show these patterns. 
Attenuated cortisol reactivity was also observed in all individuals who experienced 
sexual abuse or neglect, and elevated responses were observed in individuals carrying 
two copies of minor alleles in both SERT polymorphisms and OPRM1. Together, results 
inform a developmental model of cortisol dysregulation. Cortisol reactivity may present a 
useful endophenotype for future studies of physiological and psychological disease 
processes and treatment outcomes. 
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CHAPTER I 
INTRODUCTION 
Overview 
Variations in the activity of the stress hormone cortisol are integral components of 
daily functioning for humans, altering our physiology upon waking each morning 
(diurnal regulation) and in response to stressful experiences (reactivity). Released via the 
hypothalamic-pituitary-adrenal (HPA) neuroendocrine system, cortisol allows for the 
maintenance of diurnal rhythm of key metabolic functions; and regulates gluconeogenic, 
anti-inflammatory, and immunosuppressive processes when the body mounts short-term 
responses to stressors (i.e., allostasis; Sterling and Eyer, 1988). Over time, many 
individuals who are repeatedly exposed to acute or chronic stressors do not adapt as 
effectively and exhibit dysregulation of the HPA system – a physiological consequence 
described as allostatic load (McEwen, 1998). 
Extreme variations in cortisol release are regarded as endophenotypes of multiple 
psychological and physiological conditions. Dysregulation of cortisol functioning has 
been observed in adults with major depressive disorder (MDD; see de Kloet, Joels, and 
Holsboer, 2005), posttraumatic stress disorder (PTSD; e.g., Yehuda, 2000) most other 
anxiety disorders (see Vreeburg et al., 2010), and many externalizing disorders – e.g., 
substance use disorders (SUDs; see Rao, Hammen, and Poland, 2009) conduct disorder 
(Pajer, Gardner, Rubin, Perel, and Neal, 2001), or antisocial personality disorder (e.g., 
Shirtcliff, Granger, Booth, and Johnson, 2005). Cortisol dysregulation is also observed in 
survivors of childhood abuse or maltreatment (e.g., Fisher, Kim, Bruce, and Pears, 2012; 
Heim, Newport, Bonsall, Miller, and Nemeroff, 2001), in certain neurological conditions 
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(e.g., Huntington’s disease; Aziz et al., 2009), and as symptomatic of and contributory 
toward a variety of cardiovascular and metabolic diseases (e.g., McEwen, 1998). In these 
diverse examples, the measure that defines the construct of “cortisol dysregulation” 
varies. When one examines cortisol functioning diurnally, individuals who display a flat 
pattern – an attenuated morning rise in cortisol and higher evening levels, compared to 
normal functioning – may be considered hypoactive; others may display hyperactivity, 
with abnormally elevated levels of cortisol throughout the day. When one examines 
cortisol release in response to psychosocial stress, hyporeactivity refers to an attenuated 
cortisol release relative to normal functioning, and hyperreactivity refers to exaggerated 
cortisol release (higher peak, longer time to return to typical functioning). 
Cortisol dysregulation is dependent upon developmental experiences – e.g., early 
adversity or recent stressors – and biological characteristics – e.g., sex differences and 
other genetic variations linked to neurobiological functioning. The current study will 
consider the independent and interactive effects of these variables on cortisol responses to 
a laboratory psychosocial stress task. 
 
Neurobiology of the Stress Response 
The biological stress response in mammals is regulated by two interconnected 
neuroendocrine systems – the HPA system (also, HPA axis), and the SAM, or 
sympathetic-adrenal medullary system (Frankenhauser, 1986). A subcomponent of the 
sympathetic nervous system, the SAM system is responsible for releasing norepinephrine 
and epinephrine following exposure to threatening stimuli, allowing for the rapid “fight-
or-flight” stress response (Cannon, 1929). In contrast, the HPA system produces steroid 
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hormones called glucocorticoids (in humans, cortisol; in other mammals such as rodents, 
corticosterone) that are also released in response to stressors, but are produced more 
slowly than epinephrine, and target the brain directly (de Kloet, Rots, and Cools, 1996).  
HPA: The Long-Term Biological Stress Response 
The HPA axis is regarded as the central regulatory and control system of most 
vertebrate organisms, activated in response to emotional-cognitive processing of 
environmental stressors (e.g., Gunnar and Quevedo, 2007).  Norepinephrine released by 
the SAM system stimulates the release of CRH (corticotrophin releasing hormone) and 
AVP (arginine vasopression) in the paraventricular nucleus (PVN) of the hypothalamus. 
In concert with epinephrine, norepinephrine, and oxytocin, both CRH and AVP stimulate 
the release of ACTH (adrenocorticotropic hormone) from the anterior lobe of the 
pituitary gland, which in turn travels through the bloodstream and activates receptors in 
the adrenal cortex, leading to the production and release of glucocorticoids. Peaking 20-
40 minutes after initial exposure to environmental threat and lasting for hours, 
glucocorticoid release effects systemic metabolic and epigenetic changes throughout the 
body (Kirschbaum and Hellhammer, 1989). Glucocorticoid release regulates glucose 
synthesis in response to circadian rhythms, suppresses inflammatory and immune 
functioning, and activates receptors that regulate transcription of hundreds of 
glucocorticoid-responsive genes (de Kloet, 1991). These alterations in gene transcription 
may occur minutes or hours following the initial activation of this system, and 
downstream alterations in gene-protein-tissue production may occur for far longer 
periods of time – functionality that does not map neatly onto popular conceptualizations 
of the “flight-or-fight” SAM response (Sapolsky, Romero, and Munck, 2000). 
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Glucocorticoids bind to two types of receptors – Mineralcorticoid receptors, 
located primarily in the limbic system (MRs; deKloet, Joels, and Holsboer, 2005), and 
glucocorticoid receptors (GRs), located throughout the brain and in many organs systems 
– that act in contrast to one another. MRs mediate basal physiological processes (e.g., 
blood pressure, circadian rhythm), while GRs activate neuronal feedback pathways to the 
PVN, inhibiting CRH production and terminating the HPA response via inhibitory µ-
opiod receptor OPRM1 and endogenous cannabinoid receptor CB1 (e.g., Barna, Zelena, 
Arszovszki, and Ledent, 2004). Thus, delayed activity of cortisol in humans ultimately 
shuts down the acute stress response system, facilitating a return to cellular homeostasis 
following stress (Sapolsky et al., 2000).  
The Unique Role of CRH in the Stress Response 
Limbic cortical regions (anterior cingulated cortex, orbital and medial prefrontal 
cortices) and subcortical structures (amygdala, hippocampus, thalamus, etc.) are utilized 
in the appraisal of potential environmental stressors. The activity of these regions is 
ultimately regulated by CRH neurons (Bale and Vale, 2004). In rodent models, infusion 
of CRH into analogous brain regions intensifies anxious behaviors (e.g., Reul and 
Holsboer, 2002) and CRH neurons in these same regions sensitize to CRH given repeated 
exposure to psychosocial stressors (Butler, Weiss, Stout, and Nemeroff, 1990). Two types 
of CRH receptor neurons act in contrast, but not in opposition to one another (much like 
MR and GR; Zhao et al., 2007). Activation of CRHR1 is associated with HPA regulation 
and fearful or anxious behavior, as these receptors are found in limbic regions involved 
with processing threatening stimuli. Activation of CRHR2 is associated with depressed or 
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anxiolytic states, as these receptors are found in subcortical regions associated with basic 
bodily functions (e.g., Muller and Wurst, 2004). 
Serotonergic and Dopaminergic Alterations of the Stress Response 
Recent studies have demonstrated that serotonin is involved in both activation and 
feedback control of the HPA axis (e.g., Lesch et al., 1996, Lowry, 2002). Exposure to 
acute stress increases serotonin release in the amygdala, regions of prefrontal cortex, the 
nucleus accumbens (NAc), and the lateral hypothalamus. In animal models, serotonin 
activates the HPA system by stimulating release of CRH (Murphy and Lesch, 2008). 
Serotonin promotes downregulation of HPA activity by binding to postsynaptic 5-HT1A 
receptors, which are found in the hippocampus and amygdala. Stimulation of these 
receptors produces anxiolytic effects in rodents, and lower receptor density is associated 
with long term stress exposure (Charney, 2004).  Reduced availability of L-tryptophan (a 
precursor of serotonin) impairs this negative feedback control mechanism that terminates 
cortisol release (Porter, Gallagher, Watson, and Young, 2004).  
Exposure to uncontrollable stress also provokes dopamine release from medial 
prefrontal regions and inhibits release in NAc (Charney, 2004), suggesting amygdalar 
functioning mediates the activation of dopaminergic “reward” pathways in response to 
stress. Increases in synaptic dopamine effect changes in multiple neurotransmitters 
involved in the stress response (e.g., serotonin), which later inhibit dopamine release. 
Psychobiological Variations in Acute Stress Exposure 
Decades of stress research have demonstrated that subjective interpretations of 
environmental stimuli have direct consequences on physiological responses. Henry 
(1992) proposed that HPA axis activity is associated with situational uncontrollability 
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and perceived helplessness, while SAM activity occurs when one faces a challenge to be 
overcome. In a meta-analysis of studies linking chronic stress exposure to HPA 
functioning, Miller, Chen, and Zhou (2007) report that uncontrollable stressors, threats to 
physical integrity, or traumatic experiences lead to diurnal hypoactivity, but greater total 
cortisol release throughout the day. Controllable stressors are associated with more 
adaptive cortisol responses – higher morning rise, and truncated reactivity to the acute 
stressor. Studies of HPA axis responses to psychological laboratory stressors demonstrate 
similar patterns (Dickerson and Kemeny, 2004). The largest, most prolonged cortisol 
responses are elicited by tasks that are perceived as uncontrollable, force failure, provide 
no escape from negative consequences, or feature social-evaluative threat.  
Allostasis and Allostatic Load 
According to McEwen (1998), allostasis is the process by which an organism 
continues to adapt to ever-changing internal and external environmental cues through 
activation of neurobiological stress response systems. In the short-term, this activity is 
beneficial and necessary for survival, returning an organism to homeostasis. In the long-
run, this same activity can be deleterious to the organism’s overall functioning. Although 
these systems are designed to adapt continuously, this continuous adaptation damages the 
response system itself and associated organs and tissues. This “wear-and-tear” 
experienced by an organism over time as it continuously adapts has been termed 
allostatic load. Earlier and more serious exposure to environmental threat is associated 
with stronger and more persistent effects on biological processes. 
Cortisol responses altered by allostatic load sharply contrast with typical stress 
responses – short-term elevation of physiological activity followed by a recovery period 
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(See Figure 1; see the Appendix for all figures). Some individuals may demonstrate 
physiological responses to stress, but the recovery period does not readily occur, such 
that the individual is under a constant state of alert (i.e, hyperreactivity). Individuals who 
are acutely depressed or anxious are likely to display this elevated response, and are 
susceptible to cardiovascular disease (McEwen and Seeman, 1999). Others may not 
display reactivity at all (i.e., hyporeactivity), and are rendered susceptible to 
inflammatory and autoimmune diseases that are byproducts of hypocortisolism 
(Sternberg, 1997). They are likely to have experienced some form of early life trauma 
and their dysregulation may represent psychophysiological adaptation to the stressors 
themselves, and/or accumulation of neuroendocrine damage (Heim and Nemeroff, 2001). 
Stress and Disease 
Exposure to psychological or physiological stressors leads to changes in immune 
functioning, blood coagulation, and gene expression (Glaser, 2005; Weaver, 2009). 
Glucocorticoid elevation during stress suppresses inflammation by altering leukocyte 
functioning and redistributing cytokines. Dhabhar (2002) notes that chronic stressors are 
immunosuppressive, while acute stressors may have generally immunoenhancing effects. 
Also, acute stress tends to activate molecules that coagulate blood, contributing to 
increased risk for cardiovascular disease (e.g., von Kanel, Kudielka, Hanebuth, Preckel, 
and Fischer, 2005). Exposure to chronic childhood stress is associated with multiple 
epigenetic effects, including DNA methylation, decreased GR receptor transcription, 
altered activation of GR-responsive genes that regulate inflammation and other processes, 
and pathological consequences of these variations (McGowan et al., 2009). 
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As a consequence of what endocrinologist Hans Selye had termed General 
Adaptation Syndrome (GAS; Selye, 1936), humans are likely to experience diseases that 
arise from the breakdown of weakened or predisposed organ systems in the context of 
chronic or major stressors. In addition to cardiovascular, autoimmune, and endocrine 
disorders, stress exposure has been tied to a variety of psychopathological disorders, 
including MDD (Mazure, 1998), SUDs (e.g., Sinha, 2008) and PTSD. Chronic activation 
of the glucocorticoid stress response is also associated with premature systemic aging, 
through the shortening of telomeres (repetitive nucleotide sequences at the ends of genes 
that prevent their degradation; Epel et al., 2010) and oxidative damage to RNA 
(Aschbacher et al., 2013). 
 
Sex Differences in the Stress Response 
Sex differences observed in the prevalence of many diseases – e.g., cardiovascular 
and infectious diseases are more common in males, but autoimmune disorders are more 
common in females – may be attributable to variations in cortisol functioning (Kudielka 
and Kirschbaum, 2005). Both subjective interpretations of stressful events and individual 
variations in baseline physiological state will affect cortisol release, and both tend to vary 
in males and females. 
Human males display greater levels of basal plasma and salivary cortisol than 
females in many studies (e.g., Kirschbaum, Wüst, and Hellhammer, 1992; Tersman, 
Collins, and Eneroth, 1991). When measured during relaxation, basal cortisol levels of 
males and females do not differ significantly, but differences emerge once individuals are 
exposed to psychosocial stressors (Kudielka and Kirschbaum, 2005). Differences in 
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reactivity are only observed consistently when female participants are between puberty 
and menopause, and few significant differences are observed outside of this time period 
(e.g., Fisher, Kim, Bruce, and Pears, 2012; Nicolson, Storms, Ponds, and Sulon, 1997). In 
some studies, basal cortisol levels are higher in males only when compared to 
menstruating females during their follicular phases, and were comparable to that of males 
in the luteal phase (Kirschbaum et al., 1992).  
Sex differences are attributable to variations in neurohormonal functioning (e.g., 
Carey, Deterd, de Koning, Helmerhorst, and de Kloet, 1995). The adrenal cortices of 
females are more responsive to ACTH than those of males, as levels measured at the 
pituitary gland often do not differ between sexes (Kirschbaum et al., 1992). Females have 
demonstrated greater sensitivity to the release of AVP in neurohormonal administration 
tests (Born, Ditschuneit, Schreiber, Dodt, and Fehm, 1995). 
Estrogen release also exhibits significant effects on HPA functioning. Estrogen 
regulates GR and MR functioning in rodent models, and mediates CRH synthesis in 
PVN. In humans, higher estradiol concentrations (naturally in women or administered to 
men) are associated with attenuated cardiac output (Kajantie and Phillips, 2006). 
Estrogen alters the functioning of multiple physiological systems by increasing 
parasympathetic nervous system activity and reducing sympathetic activity. Estrogen also 
stimulates the production of corticosteroid-binding globulin (CBG), which binds with 
free cortisol in plasma and reduces cortisol levels (Kirschbaum et al., 1992). 
Taylor and colleagues (2000) propose that females may exhibit wholly different 
response pattern to stress – wherein they may “tend-and-befriend” as opposed to males 
who would fight or flee – attenuating SAM and HPA activation via oxytocin release, 
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which is stimulated by estrogen. Oxytocin – a hypothalamic neurohormone that 
modulates intimacy, maternal bonding, and attachment – produces anxiolytic effects in 
rodents and primates, and promotes affiliative behavior in response to stressors. 
The developers of the Trier Social Stress Test – a laboratory psychosocial stress 
task (TSST; Kirschbaum, Pirke, and Hellhammer, 1993) – note that some sex differences 
are likely due to gender-mediated perceptions of the socially-ostracizing task, since other 
forms of stress induction (CRH injection, bicycle ergometry) do not demonstrate such 
differences. Males also demonstrate elevated cortisol responses during anticipation of this 
stressor, while females showed reductions in cortisol release after starting the task.  In 
one study of young adults, Stroud and colleagues (2002) demonstrated that females 
exhibited greater cortisol responses to social rejection, while males responded more 
intensely to tasks that involved achievement, such as the TSST. 
 
How Early Adversity Shapes the Stress Response 
The damaging effects of long-term HPA activation are noteworthy throughout the 
lifespan, but exposure to stress during childhood is particularly impactful on subsequent 
long-term HPA dysregulation. Characteristics of cortisol dysregulation vary depending 
on age or developmental timing of exposure; and type, severity, or duration of exposure 
to environmental adversity (Fisher and Gunnar, 2010).  
After birth, maternal nurturing behaviors regulate how many GRs will develop in 
the hippocampus (via methylation, which prevents transcription of genes; see Weaver et 
al., 2004). Increased hippocampal GR density is associated with maternal attention and, 
therefore, more efficient termination of stress responses. Having fewer GRs is associated 
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with maternal neglect, slower mobilization of the HPA response, poorer regulation of the 
response (i.e., slower return to baseline), and ultimately an increased vulnerability to the 
effects of allostatic load (Meaney and Szyf, 2005; Weaver et al., 2001). 
Childhood Attachment 
In general, children who have secure attachment relationships do not show 
elevations in HPA activity in response to distressing laboratory and naturalistic 
situations; toddlers with insecure attachment relationships generally exhibit elevated 
cortisol levels in response to such stressors (e.g., Gunnar and Donzella, 2002). Children 
in disorganized or disordered attachment relationships with their caregivers experience 
high variability in their stress responses, often characterized by elevated and poorly 
regulated HPA activity in preschool years, and equally dysregulated mood and behavior 
in the presence of the caregiver (e.g., Halligan, Herbert, Goodyer, and Murray, 2004). 
Further, dysfunctional parenting is associated with cortisol increase in children during 
parent-child discussions of conflict (Granger, Weisz, and McCracken, 1996). 
Early Life Trauma and Neglect 
Maltreatment during development leads to alterations in the stress response 
systems, which in turn produce maladaptive outcomes (see Bremner and Vermetten, 
2001; De Bellis, 2001; or Heim and Nemeroff, 2001). Traumatic family events involving 
conflict (punishment, quarrelling, fighting) tend to be associated with brief periods of 
elevated cortisol activity in all children, but these return to more normal levels of 
functioning after a short period of time. Children repeatedly exposed to more severe 
traumatic events or neglect display patterns altered by exposure.  
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Children exposed to long-term early abuse display attenuated cortisol release later 
in life diurnally (e.g., Lovallo, Farag, Sorocco, Cohoon, and Vincent, 2012) and in 
response to stressors (e.g., Cicchetti, Rogosch, and Oshri, 2011). Maltreated preschool-
aged children (subjected to either physical abuse or neglect) exhibit less cortisol 
reactivity in general, and in one study demonstrated especially low levels on days when 
the classroom environment was filled with conflict or fighting (Hart, Gunnar, and 
Cicchetti, 1995). If these children were also exposed to prenatal substance abuse, they are 
more likely to demonstrate hyporesponsiveness to the TSST-C before adolescence 
(Fisher, Kim, Bruce, and Pears, 2012). Sexually abused girls show blunted ACTH 
responses when CRH injections are administered (De Bellis et al., 1994). Also, both 
infants reared in orphanages and domestically-neglected children placed in foster care 
demonstrate significant cortisol dysregulation, characterized by low morning levels and 
altered diurnal rhythms (Carlson and Earls, 1997; Gunnar and Fisher, 2006). 
Adolescents and adults exposed to severe stressors display exaggerated episodic 
cortisol responses, experience long-term upregulation of HPA activity given repeated 
exposure (e.g., Kirschbaum et al., 1995). However, individuals who were abused as 
children may be more likely to display hyposecretion as adults when exposed to acute 
stressors (symptomatic of PTSD). These variations likely represent cross-sections of the 
developmental degradation of HPA functioning. De Bellis (2001) argues that cortisol 
dysregulation may change over the life course – a byproduct of chronic allostatic load – 
though he notes that many structural effects of maltreatment persist indefinitely. Indeed, 
many structural changes in the hippocampus and corpus callosum may not manifest until 
later in life, but are activated by early life trauma (Andersen and Teicher, 2004). 
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Genetics of the Stress Response 
Variations in genes that encode proteins regulating neuroendocrine functioning 
are associated with phenotypic variations in cortisol release. Many studies of reactivity 
have considered Single Nucleotide Polymorphisms (SNPs) – single alleles (or “letters” 
that correspond to the names of nucleotides) that vary in a molecular DNA sequence. 
Other studies have considered the phenotypic effects of longer sections of DNA that vary 
in length or nucleotide sequence – Variable Number Tandem Repeats (VNTRs). 
Genetic Variations in HPA 
When measured via urinary free cortisol, HPA activity appears to be significantly 
heritable, with estimates averaging 50% (Bartels, de Geus, Kirschbaum, and Sluyter, 
2003); genetic variations in GR feedback mechanisms show similar heritability. The 
heritability of responses to laboratory stressors – behavioral or chemical – have not been 
conclusively studied, but at least one twin study suggests very high heritability (>97%) 
for sustained stress response. GRs mediate the effects of glucocorticoids on gene 
transcription by binding directly to regions of the genome or by interacting with other 
neurochemicals that regulate transcription (e.g., AP-1, NF-κB; see Wust et al., 2004, for a 
review). Cortisol and other glucocorticoids bind to GR receptors, which translocate to the 
nucleus of the cell, bind to specific regions of the genome, and modulate mRNA 
transcription. Several polymorphisms in GRs and MRs moderate cell-specific GR/MR 
expression and ultimately behavioral responses to stress, but are very rare (e.g., a variant 
in Asn363Ser exon 2 is associated with elevated reactivity; a variant in BclI is associated 
with attenuated reactivity; DeRijk and de Kloet, 2005, 2008). A more common minor 
allelic variation in Mineralcorticoid receptor gene SNP (MR I180V; rs5522) is associated 
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with increased depressive symptoms, and increased cortisol response following the TSST 
(DeRijk, van Leeuwen, Klok, and Zitman, 2008).  
Genetic Variations in SAM 
To date, several functional polymorphisms in genes associated with 
norepinephrine release (such as the norepinephrine transporter, NET) have been studied 
in the context of multiple clinical conditions, but their relationships with the stress 
response system have yet to be established. A notable exception is found in the catechol-
O-methyltransferase gene (COMT), where a common polymorphism found in humans 
(Val158Met, causing a substitution of the amino acid Methionine for Valine at codon 
158; rs4680) contributes to a four-fold decrease in enzyme activity for minor allele 
carriers (e.g., Chen et al., 2004). Since the COMT gene produces a protein that 
inactivates norepinephrine and dopamine, carriers of the minor “Met” variant are more 
susceptible to phenotypic consequences of dysfunction. Multiple studies have associated 
variations in this polymorphism with anxiety-related personality phenotypes (i.e., 
neuroticism; Stein, Fallin, Schork, and Gelernter, 2005) and risk for unipolar or bipolar 
depression (Mandelli et al., 2006). In conjunction with 5-HTTLPR, COMT moderates the 
relationship between life stress and MDD, wherein carriers of the minor allele are more 
likely to become depressed, and risk increases significantly given exposure to life stress.  
COMT alters HPA activity, as homozygous carriers of “risk” Met alleles have 
demonstrated elevated diurnal cortisol release relative to carriers of “protective” Val 
alleles (Walder et al., 2010), and greater cortisol release following the TSST (Armbruster 
et al., 2012). The likely mechanism of this alteration is through reduced breakdown of 
norepinephrine and promotion of ACTH release released during exposure to 
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environmental stressors, leading to prolonged activation of the HPA system (Jabbi et al., 
2007). Further, these minor allele carriers demonstrate reduced µ-opioid binding 
potential, greater HPA activation when a µ-opioid chemical blockade is introduced, and 
generally reduced pain tolerance (regulated by µ-opioid activity). 
Genetics of Limbic CRH Functioning 
Polymorphisms in CRHR1 have been associated with variations in response to 
psychosocial stress. Mahon and colleagues (2013) reported that minor alleles of several 
SNPs – rs110402, rs242924, and rs7209436 – were associated with reduced levels of 
cortisol in response to the TSST in “one of the largest TSST cohorts yet examined” (n = 
368). Also, Sheikh and colleagues (2013) identified several SNPs within the CRH system 
(including rs1776310 in CRHR1) that predicted reduced reactivity in children who 
carried minor alleles of these genes. CRHR1 has demonstrated inconsistent interactive 
effects in the prediction of cortisol reactivity, which are discussed in the next section. 
Variations in CRHR1 are associated with the occurrence of psychopathology in 
the presence of life stress, including alcohol abuse (SNP rs1876831; Blomeyer et al., 
2008) and MDD (SNP rs110402; Papiol et al., 2007). SNP rs110402 also moderated the 
effects of child abuse on adult depressive symptoms (Bradley et al., 2008), such that 
adults who are homozygous for the risk allele (GG) who have experienced child abuse 
are most likely to be depressed, while homozygous AA carriers are protected from the 
depressogenic effects of child abuse later in life. 
Genetic Variations in the Serotonergic System 
The serotonin transporter (SERT) gene-linked polymorphic promoter region (5-
HTTLPR) is a widely-studied VNTR polymorphism, wherein individuals generally carry 
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14- or 16- repeats of a three-letter sequence, resulting in a 44-base-pair deletion/insertion 
variation and “short” or “long” 5-HTTLPR alleles. In general, carrying at least one copy 
of the short allele is associated with reduced transcription, reduced SERT expression, and 
reduced serotonin reuptake. An associated SNP (rs25531) interacts with 5-HTTLPR to 
alter further serotonergic functioning in some individuals, rendering “long” alleles 
“short” functionally (Wendland et al., 2006). 
SERT contains a glucocorticoid response element, contributing to elevated 
emotional responses in the presence of stress-induced HPA activity. Dexamethasone 
administration increases SERT gene activity and serotonin uptake capacity (Glatz, 
Mossner, Heils, and Lesch, 2003). Both rodents who carry short alleles of the equivalent 
gene to SERT in humans (SLC6A4) and those who have had the serotonin transporter 
gene knocked out exhibit increased HPA activity in response to acute stressors (Murphy 
and Lesch, 2008). Variations in human cortisol reactivity in response to laboratory stress 
are also moderated by the 5-HTTLPR polymorphism, such that carriers of the short allele 
exhibited higher and prolonged cortisol responses to laboratory stressors (e.g., in 
adolescent girls, Gotlib, Joorman, Minor, and Hallmayer, 2008; and in young adults, Way 
and Taylor, 2010). A recent meta-analysis by Miller and colleagues (2013) reports a 
small effect for the short allele of 5-HTTLPR contributing to elevated cortisol reactivity 
to psychosocial stress across studies. Interactive effects on reactivity associated with 5-
HTTLPR are inconsistent (See next section). 
The short allele of 5-HTTLPR is associated with increased anxiety and 
neuroticism in humans (e.g., Lesch et al., 1996); as well as multiple psychopathological 
outcomes, such as MDD (Caspi et al., 2003), SUDs (Covault et al., 2007), and anxiety 
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disorders (Hariri and Holmes, 2006) given exposure to life stressors. Another 
polymorphism in SERT (rs25532) is associated with liability for obsessive compulsive 
disorder (Wendland et al., 2008), but has not yet been associated with variations in 
cortisol reactivity or other phenotypic manifestations of dysfunction. 
Genetic Variations in the Dopaminergic System 
Although dopamine binds to at least five different receptors, the DRD2 receptor 
has received considerable attention in psychopathology literature. Specifically, a 
polymorphism referred to as Taq1a – located within the ankyrin repeat and kinase 
domain containing 1 gene (ANKK1) 9.5 Kilobase-pairs downstream from the coding 
region of the DRD2 gene – has been identified as highly discriminatory among patients 
and control individuals. The A1 allele of ANKK1 is generally associated with a reduced 
number of dopamine binding sites in the brain (e.g., Thompson et al., 1997) and several 
pathological outcomes, including alcohol abuse (Munafo, Matheson, and Flint, 2007), 
nicotine dependence (Swan et al., 2005), and amphetamine abuse (Ujike, 2009). The A2 
polymorphism has been found to moderate the association between life stress and MDD, 
such that homozygous A2 carriers are at increased risk for depression following stressful 
life events (Elovainio et al., 2007). 
Polymorphisms in genes related to dopaminergic functioning have not been 
extensively researched relative to cortisol reactivity. A variation in a dopamine receptor 
D4 gene (the 7R VNTR) is associated with attenuated reactivity, and interacts with 
variations in 5-HTTLPR to produce greater drops in cortisol release (Armbruster et al., 
2009). The integration of this system with other components of the human stress response 
suggests it may be involved. 
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Genetic Variations in the Opioid System 
Opiates (e.g., heroin, morphine, hydrocodone, etc.) interact with µ-opioid 
receptors that drive reward and pain responses, as well as the human stress response. This 
system operates with the dopaminergic reward pathway, such that motivation for opiates 
in addicted mammals originates from mesolimbic dopaminergic structures. In rodents 
exposed to laboratory social stressors, µ-opioid mRNA expression is elevated (e.g., 
Nikulina, Miczek, and Hammer, 2005).  
A functional polymorphism in the µ-opioid receptor gene (OPRM1 N40D; SNP: 
rs1799971) has been shown to modify expression of the OPRM1 transcript and to modify 
β-endorphin binding to the µ-opiod receptor (e.g., Kreek et al., 2005). This 
nonsynonymous SNP substitutes an Aspartic Acid (D) for an Asparagine (N) in the 
extracellular domain of the receptor. The D/Asp40 variant of this allele is associated with 
a three-fold increase in β-endorphin affinity, increasing inhibition of CRH neurons and 
reducing HPA stress reactivity (Bond et al., 1998). The minor N allele is associated with 
increased levels of baseline cortisol and with increased cortisol response to both 
naltrexone administration and to laboratory stressors (e.g., Chong et al., 2006; 
Hernandez-Avila et al., 2007). 
 
Gene-Environment Interactions in Cortisol Reactivity 
Studies of gene-environment (GxE) interactions in psychopathologies (such as 
MDD or SUDs) demonstrate associations between genes related to HPA functioning and 
environmental threat exposure, suggesting cortisol dysregulation may be a mechanism 
driving pathogenesis of these disorders. 
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CRHR1 Interactions 
SNPs in the CRHR1 gene have differentiated participants’ cortisol reactivity and 
diurnal regulation given exposure to adversity. Carriers of the GG “risk” genotype of 
SNP rs242924 who were maltreated as children display elevated cortisol release 
following the Dexamethasone/CRH test (Tyrka et al., 2009). Also, in another study of 
SNP rs110402, male carriers of the A “protective” allele demonstrated attenuated 
reactivity to this test relative to female carriers and male homozygous carriers of the 
“risk” allele; when childhood abuse history was considered, abused female A-allele 
carriers displayed elevated cortisol reactivity relative to abused male carriers (Heim et al., 
2009). Carriers of a “risk” haplotype including SNP rs110402 have demonstrated 
attenuated diurnal cortisol regulation if they were abused or maltreated as children; 
however, non-abused carriers of the risk haplotype resemble those individuals who carry 
protective copies of the gene, demonstrating expected diurnal cortisol variations 
(Cicchetti et al., 2011).  
5-HTTLPR Interactions 
Numerous studies have reported that carriers of two copies of the short (S) allele 
of 5-HTTLPR showed increased cortisol release following a laboratory stressor when 
compared to carriers of at least one long (L) allele (Miller et al., 2013). Yet, findings 
regarding how this gene interacts with stressful life experiences remain mixed. Adult 
male homozygous S carriers who experienced recent stressful life events displayed 
elevated cortisol reactivity (Alexander et al., 2009), but another study of young adults 
found the opposite – carriers of at least one S allele showed generally reduced cortisol 
reactivity relative to homozygous L allele carriers, who also showed attenuated cortisol 
20 
release if they had experienced stressful life events during the first five years of 
childhood (Mueller et al., 2011).  
5-HTTLPR has also been studied in concert with other gene implicated in cortisol 
dysregulation. Carriers of a vulnerability in a dopaminergic receptor D4 gene who also 
carry long allele subtype LA of 5-HTTLPR demonstrated attenuated reactivity compared 
to those who carry long LS or short alleles (Armbruster et al., 2009). Also, children 
exposed to laboratory stress demonstrated divergent effects of short alleles in 5-HTTLPR 
given variants of another SNP in a BDNF gene (Dougherty et al., 2010) – carriers of Met-
alleles in BDNF displayed low baseline levels of cortisol, but significant reactivity; Val-
allele carriers displayed low levels of cortisol throughout the stress tasks. Overall, the 
diversity of these findings suggests that stable interactions involving 5-HTTLPR may be 
difficult to detect. 
 
The Present Study 
 This study will consider how an individual’s sex, genotype, and exposure to early 
and recent adversity shape cortisol responses to a laboratory psychosocial stress task (the 
TSST). Specifically, it will report on a simultaneous assessment of multiple GxE 
interactions implicated in previous research on cortisol functioning, including those 
related to HPA activation and termination, and systems that function reciprocally with 
HPA activity. 
This study will test the following hypotheses concerning cortisol reactivity: 
1. Independent effect of sex on reactivity – Females will display attenuated 
responses to psychosocial stress, relative to males. 
21 
2. Independent environmental effects on reactivity – Individuals who were 
exposed to childhood adversity (physical abuse, sexual abuse, or neglect) 
will display attenuated responses to psychosocial stress, compared to 
individuals exposed to less or no early adversity. Also, individuals 
exposed to recent stressful life events or difficulties will display attenuated 
reactivity, compared to individuals not exposed to recent adversity. 
3. Independent genetic effect on reactivity – Polymorphic variations at sites 
that encode functional components of the HPA system will alter cortisol 
reactivity, including those associated with the following: 
a. Response Activation: 
i. COMT SNP rs4680. Homozygous carriers of risk alleles 
will demonstrate elevated response to psychosocial 
stressors. 
ii. CRHR1 SNPs rs110402 and rs1876831. These genes will 
demonstrate interactive effects with adversity and sex. 
iii. MR SNP rs5522 in gene NR3C2. Homozygous carriers of 
risk alleles will demonstrate elevated response to 
psychosocial stressors.  
b. Termination: 
i. SERT. Carriers of the short allele of 5-HTTLPR will 
display elevated reactivity with or without exposure to 
adversity. Also, carriers of the risk allele of SNP rs25532 
will display elevated reactivity. 
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ii. OPRM1 SNP rs1799971. Carriers of minor alleles will 
demonstrate a prolonged response to the TSST. 
c. Associated Activation: 
i. DRD2. The effects of SNP rs1800497 in ANKK1 on 
cortisol reactivity will be explored. 
4. Interactive effects on reactivity – Individuals who carry multiple 
vulnerabilities to altered cortisol functioning (e.g. exposure to early life 
stress, genetic polymorphisms) will display more extreme forms of 
reactivity than individuals who do not carry such vulnerabilities. This 
study will assess all potential interactions, with particular consideration 
given to the following: 
a. CRHR1 x Early Adversity x Sex – reported by Heim et al. (2009); 
Tyrka et al. (2009) report a significant GxE effect for another SNP. 
b. 5-HTTLPR x Early Adversity – reported by Mueller et al. (2011) 
in young adults, but not supported in a meta-analysis by Miller et 
al. (2013). 
c. 5-HTTLPR x Recent Adversity – reported by Alexander et al. 
(2009), but not supported in recent meta-analysis. 
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CHAPTER II 
METHODS 
Overview of Study and Design 
Data for this project were obtained from an ongoing longitudinal cohort-
sequential study assessing risk factors associated with substance use in children, 
adolescents, and emerging adults, the Oregon Youth Substance Use Project (OYSUP; 
Andrews et al., 2003). One-thousand seventy-five students from five grade cohorts (1
st
 
through 5
th
 grade at the first assessment, during the 1998-1999 academic year) were 
assessed annually until one year after completing high school. At age 20-22, students 
primarily from two cohorts (in 3
rd
 and 4
th
 grade during the first assessment) completed 
interviews about recent stressful experiences (the Life Events and Difficulties Schedule, 
LEDS; Brown and Harris, 1978) and their childhood care experiences (the Childhood 
Experiences of Care and Abuse interview, CECA; Bifulco et al., 2003), and participated 
in a laboratory-based task designed to induce stress (the TSST; Kirschbaum, Pirke, and 
Hellhammer, 1993). Saliva samples were obtained to assay cortisol preceding and 
following the TSST, and also to assay specific polymorphisms of candidate genes that 
may be related to the human neuroendocrine stress response. 
 
Participants 
 The 1075 students originally recruited for OYSUP were randomly selected from 
15 elementary schools in one school district in Western Oregon (see Andrews et al., 
2003, for additional information about the representativeness of the original sample). 
Students (N = 403) in the current study were contacted within one year of their 21
st
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birthdays (ages 20-22; Mean age = 21.14) to participate in a day-long assessment. The 
current sample was primarily middle- and lower-middle class European-Americans 
(84.6%) and Latinos (6.5%), with a nearly-equal proportion of males (n = 189, 50.7%) 
and females. Many of these students had been or were currently enrolled in college at the 
time of assessment (64.6% of students reported at least some coursework after high 
school; only 7.0% of students did not complete high school). Most students were 
employed during the last six months (83.7%), and many were employed currently 
(70.3%). A small number (4.0%) were active-duty or reserve military personnel. 
Thirty individuals (19 females, 11 males) did not participate in the TSST. Five of 
these individuals were pregnant at the time of the assessment, and the remaining 25 
individuals declined participation. Other than being disproportionately female, this subset 
of individuals did not differ in terms of demographic or adversity variables from the rest 
of the sample. Additionally, five individuals had incomplete or missing genetic or cortisol 
data (two individuals declined to provide a saliva sample for DNA analysis, and the 
cortisol samples provided by three individuals could not be assayed). 
Attrition 
Cohorts Three and Four consisted of 450 students who participated in the first 
OYSUP assessment. Forty-seven of these individuals did not participate in the age 20-22 
assessment. Demographic differences were not observed between individuals who 
participated in the first assessment and those who participated in the current assessment. 
These individuals did not significantly differ from study participants in terms of 
demographics, parental education, childhood SES (measured by free/reduced lunch in 
grade school and maternal education level) or racial composition.  
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Assessment Procedures and Interviews 
At age 20-22, participants were assessed at Oregon Research Institute (ORI; 95% 
completed within one day; Mean participation time = 5.55 hours). Most participants were 
interviewed in the morning, and participated in a laboratory-induced stress task in the 
afternoon. Before the stress task, participants provided saliva samples to assay DNA and 
baseline cortisol concentrations. Additional saliva samples were collected to assess 
cortisol reactivity in response to the stress task.  
LEDS 
Considered the gold standard for assessing, defining, and rating life stressors and 
long-term difficulties, the LEDS employs an interview-based, contextual threat 
methodology. The LEDS is a semi-structured interview that identifies discrete events or 
chronic difficulties in all life domains (school, work, living arrangements, child-rearing, 
finances, criminal activity, health, romantic and platonic relationships, and other events), 
placing these occurrences in the context of the interviewee’s life, and allowing for 
assessment of immediate and long-term threat, event focus and independence. Events 
were defined as singular occurrences lasting a couple weeks at most. Difficulties were 
ongoing problems associated with a life domain that lasted for at least a month. 
Participants were interviewed about events and difficulties that occurred during 12 
months preceding date of interview. 
Using manuals providing thousands of case examples, raters who were blind to 
the interviewee’s subjective responses assigned standardized ratings to events and 
difficulties from cases presented by the interviewer. For this study, events that were rated 
1 or 2 in terms of long-term threat (on a five-point scale, where lower numbers indicate 
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greater threat) were counted as stressful life events (SLEs). A high rating of long-term 
threat suggests that the negative effects of a SLE will be felt for weeks or months 
following the event, despite the level of immediate impact. Similarly, chronic difficulties 
were rated in terms of threat on a seven-point scale, where ratings of 1 or 2 applied to 
high threat difficulties. High threat difficulties have no immediate sign of resolution, and 
may contribute to significant ongoing life problems for the foreseeable future. Event or 
difficulty domain was not evaluated in this study. Instead, individuals were dichotomized 
according to whether they experienced a SLE during the last year or not; also, they were 
dichotomized according to exposure to a high threat difficulty during the last year or not. 
CECA 
Developed using the same contextual-threat methodology as the LEDS, the 
CECA was used to assess early childhood adverse experiences. The CECA is a semi-
structured interview that collects data on five domains – antipathy, hostility, or criticism 
directed at a participant by a childhood caregiver; emotional or material neglect from a 
caregiver; psychological abuse perpetrated by household members; physical abuse, 
including punishment; and sexual abuse by any perpetrator. In previous research, these 
domains have been associated with lifetime occurrence of mood and anxiety disorders, 
and are also associated with substance use disorders. Although both instruments are 
retrospective interviews, and many participants cannot vividly recall some aspects of 
childhood functioning, an interview-based method is more likely to capture accurate 
information when compared to a questionnaire covering the same information (McQuaid, 
Monroe, Roberts, Kupfer, and Frank, 2000).  
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A team blind to the subjective reports of the interviewees rated the severity of 
abuse by each caregiver or perpetrator within each domain (Antipathy; Neglect; Physical, 
Psychological, and Sexual Abuse) using a 5-point ordinal scale. A score of one indicates 
the highest level of severity, and four indicates a low level of severity; if no abuse was 
reported within a domain, a summary score of five was assigned to the participant. Case 
examples and standardized rules were used to guide ratings, and scores were dated to the 
nearest year of age of the participant. Summary variables for a given participant were 
generated based on the highest severity score reported before age 12 within a domain. 
To reduce the number of variables examined in final regression equations, only 
three domains of abuse were utilized – physical and sexual abuse, and neglect. Neglect 
was chosen over Antipathy and Psychological Abuse for several reasons. Neglect 
demonstrated more consistent (yet comparable) relationships with genetic and cortisol 
variables in preliminary analyses, compared to Antipathy, Psychological Abuse, or an 
average of all three psychosocial abuse variables. The variable was strongly correlated 
with Antipathy (r=0.54), and to a lesser degree with Psychological Abuse (r=0.42). Also, 
it demonstrated the most favorable psychometric properties of the three variables (range, 
skew, etc.). This resulted in three independent measures of early adversity, with lower 
values representing more severe occurrences of abuse in childhood. 
 
Psychosocial Stress Task and Cortisol Data Collection 
TSST 
The Trier Social Stress Test (Kirschbaum et al., 1993) is a standardized laboratory 
procedure used to assess cortisol reactivity to a moderate psychosocial stressor. This 
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procedure has previously been established to raise salivary cortisol levels two- to three-
fold in at least 70% to 80% of participants, in addition to evoking similar cardiovascular 
and affective responses (Kudielka, Hellhammer, and Wüst, 2009). These effects are 
attributed to the uncontrollable and evaluative nature of two tasks – a speech delivered in 
front of an audience, and a mental arithmetic assignment – which are known to provoke 
HPA reactivity. After meeting two unknown confederate “scientists” who rate behaviors 
and direct the tasks, participants prepared for a speech about their qualifications for a 
hypothetical job. Upon returning to the evaluation room, they delivered the speech for 
five minutes, and were then instructed to perform mental arithmetic for five minutes 
(either subtraction or addition in intervals of 13). The confederates were instructed to 
show no emotional or supportive reactions to task performance, instead informing the 
participant of additional time remaining for the speech or errors during the math task. 
It was anticipated that 20% to 30% of participants in the TSST might not 
demonstrate cortisol reactivity (Kudielka et al., 2009), so two additional measures of 
stress reactivity were utilized to validate the salivary data – changes in heart rate (HR) 
and emotional state. Self-reported ratings of positive and negative affect (Subjective State 
Scale; al’Absi, Hatsukami, Davis, and Wittmers, 2004) completed before and after the 
TSST task were compared. On average, most participants showed changes in affect 
following the TSST [decreases in positive affect (t(372)=-11.77, p<.001) and increases in 
distress (t(372)=26.65, p<.001)]. 
To record HR variability, most participants (n = 347) wore a commercially-
available digital heart rate monitor (CMS 50-F; ChoiceMed Electronic Tech Co., Beijing, 
China) on the wrists of their non-dominant arms, and heart rate data were recorded to the 
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device using a rubber finger probe
1
. Twenty percent (n = 70) of these participants also 
wore a second heart rate monitor that utilized a probe strapped to the chest, considered 
the gold-standard in psychometric assessment (Polar RSX-800; Polar Electro, Kempele, 
Finland). Data from the chest and finger probes were nearly identical over the course of 
the TSST for these participants (r = 0.94, p < .001), validating the finger probe data. 
Changes in HR during the preparation period were compared to changes following 
termination of the stress task. As a group, all participants showed significant changes in 
heart rate following the task – a quadratic trend, peaking during the ten-minute period 
following termination of the TSST [F(1, 345) = 33.45, p<.001]. 
As expected, nearly 25% of participants displayed either unexpected (e.g., >1 SD 
than mean change) or no changes in HR, affect, or cortisol release during the TSST, but 
no participants displayed unusual changes in all three constructs. Thus, no cases were 
dropped from analyses, and these individuals were considered hyporeactive. 
Cortisol 
Salivary free cortisol was collected using salivettes (Salimetrics, State College, 
PA) before, during, and after the TSST at six time points – once after a 20 minute 
relaxation period preceding the TSST (t1), once after meeting the panel of TSST 
“scientist” evaluators (t2 – approximately 10 minutes after t1), once immediately after 
completing the speech and arithmetic tasks (t3 –approximately 20 minutes after t2), and 
three more times following the tasks [10 minutes (t4),  20 minutes (t5), and 50 minutes 
(t6) after t3 collection]. Peak cortisol release was captured by the t4 collection, 30 
                                                 
1
 HR data collection was initiated after 30 participants had been evaluated. The self-reported affect and 
cortisol data obtained from these individuals did not significant differ from the rest of the sample. Further, 
their affect data showed no anomalies, so their cortisol data were included without HR validation. 
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minutes after initial stress exposure (t2). Cortisol returns to pre-task levels after one hour 
for most individuals, and this was reflected in the t6 collection. 
  Saliva collection occurred during the late afternoon and evening, when 
participants return from a lunch break (15:00-17:00h), allowing for control of diurnal 
variation. Since salivary cortisol can be affected by tobacco, food or drink, the baseline 
saliva sample was collected at least two hours after lunch, following a 20 minute 
observed rest period in the laboratory. All participants were encouraged to drink water 
throughout the day to promote salivation. Further, women were scheduled during the 
luteal phase of their menstrual cycles (days 15-26), controlling for estrogen levels.  
At each collection time, participants placed cotton swabs in their mouths until 
these were saturated with saliva. The swabs were placed the salivettes, which were stored 
at -20°C and later shipped on dry ice to Salimetrics. Salivary cortisol was assessed by 
immunoassay with mean intra- and inter-assay coefficients of variation of 3.5% and 
5.1%, respectively. Two assays per sample were averaged to assess cortisol levels at each 
collection time, yielding highly consistent results (r = 0.99, p<0.001).   
These averages of salivary free cortisol over time were used to obtain measures of 
area under the curve (Pruessner, Kirschbaum, Meinlschmid, and Hellhammer, 2003) – 
area with respect to ground or zero (AUCg), measuring the total cortisol release across 
time; and area under the curve with respect to increase (AUCi), measuring reactivity to 
the stress task by accounting for change relative to baseline (t1 assay). AUCg is 
calculated by summing the area of the five trapezoidal shapes created between the x-axis 
and each cortisol sampling point over a given time interval (t1 to t2, etc.). AUCi is 
calculated by multiplying the t1 value by the sum of all time differences {mean 1 * [(t2 - 
31 
t1) + (t3 - t2) + (t4 - t3), etc. ]} and subtracting this value from AUCg. Subcomponents of 
AUCi were also calculated for each individual – Rise, defined as the area of AUCi from 
t2 to peak (t4), representing activation of the HPA system; and Decline, defined as the 
area from peak to t6 collection, representing the termination of HPA functioning. An 
attenuated or elevated Rise in response to the stressor, extreme AUCi/AUCg values (high 
or low), and reduced or elevated Decline were all considered forms of cortisol 
dysregulation. A visual depiction of these constructs is shown in Figure 2. 
 
Genetic Polymorphisms 
Candidate SNPs and VNTR sequences were selected based on a priori association 
with neurobiological variations in the human stress response. These polymorphisms 
showed the greatest effects across the most studies, and include the following: 
1. ANKK1 SNP rs1800497  
2. COMT SNP rs4680 
3. CRHR1 SNP rs110402 
4. CRHR1 SNP rs1876831 
5. MR SNP rs5522 
6. OPRM1 SNP rs1799971 
7. SERT SNP rs25532  
8. SERT VNTR 5-HTTLPR 
Saliva collection for DNA was performed using commercially available kits 
(Oragene®•DNA 10 Self-Collection Kit, OG-500; DNA Genotek, Ontario, Canada). 
Salivary collection carries several benefits – higher quality of DNA, and preservation and 
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stabilization of samples relative to buccal swabs; non-invasive, safe, and painless 
collection relative to blood draw. Participants provided 2 mL of saliva into each 
collection tube before participating in the TSST and cortisol collection. When capped, the 
contents were stabilized by a reagent released by the container. DNA samples were stored 
and shipped to a laboratory at SRI, International (SRI, Menlo Park, CA) at room 
temperature. DNA was extracted from saliva samples using Oragene® purifier and 
ethanol precipitation (Nishita et al., 2009) using the manufacturer’s protocol for manual 
purification of DNA from 4.0 mL, PD-PR-015 Issue 3.1 instead of 2.0 mL. DNA was 
quantified by OD, Quant-iT™ PicoGreen® dsDNA Reagent (Invitrogen™, Carlsbad, 
CA), and qPCR (Nishita et al, 2009).   
Genotyping of candidate gene polymorphisms was performed at SRI using 
standard TaqMan® assays on a ViiA7™ Real-Time PCR system from Life Technologies 
with the exception of the following: SNP rs25532 was genotyped using primers and 
custom Taqman® probes (Wendland, et al, 2008). The genotyping of the 5-HTTLPR 
VNTR was performed using both a restriction fragment length polymorphism method 
(RFLP; Wendland, et al., 2006) and a Taqman® assay (see Hu et al., 2006, for a 
description) as stage one. Two samples (0.5%) of the total subjects genotyped were 
discordant between the two methods for the 5-HTTLPR genotyping and were changed to 
undetermined. SNP rs25531 was also genotyped using the Wendland et al. (2006) RFLP 
method. All genotyping was performed with positive and negative controls. The 
minimum genotype completion rate was 99.0%, for SNP rs25532. 
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Hardy-Weinberg Equilibrium 
Hardy-Weinberg (H-W) equilibrium refers to the distribution of alleles in a 
population, where homozygous and heterozygous carriers of alleles will remain in 
balanced ratios across generations. Violations of H-W equilibrium suggest an 
environmental influence on the distribution of genes.  The distribution of alleles in the 
sample data was examined using Haploview 4.2 (Broad Institute, Cambridge, MA), and 
most genes were found to be in H-W equilibrium, evidenced by non-significant χ2 
deviation tests (ps range 0.27-0.69). Exceptions include CRHR1 SNPs (rs110402, 
p=0.02; rs1876831, p=0.11) and COMT SNP rs4680 (p=0.06). For these genes, 
participants displayed minor allele frequencies higher than what is expected by chance. 
Since analyses will only compare homozygous minor allele carriers to all others, these 
violations of equilibrium were ignored. 
Linkage Disequilibrium 
Linkage Disequilibrium (LD) refers to alleles at two or more loci that are 
associated with each other. LD is most often calculated for alleles located on the same 
chromosome, since linked alleles tend to be close together in the genome. Only SNPs 
within CRHR1 and SERT were correlated with one another, so LD was calculated for 
these. Both pairs of SNPs were found to be in strong LD (CRHR1: rs110402 and 
rs1876831, D’=0.98, 95% CI: 0.91-1.00; SERT: rs25531 and rs25532, D’ = 1.00, 95% 
CI: 0.19-1.00), suggesting that their effects are interpretable independently.   
Triallelic versus Biallelic Variations in 5-HTTLPR 
Recent studies of SERT have identified another SNP (rs25531) that alters 
functional expression of SERT (Wendland et al., 2006). Thus, carriers of the “risk” allele 
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of rs25531 who do not carry short alleles of 5-HTTLPR may still display ineffective 
serotonergic reuptake and transport. This has been described in literature as a “triallelic” 
variation in SERT. Separately, this study incorporated three iterations of this 
vulnerability into models predicting reactivity – 1) the 5-HTTLPR variants alone; 2) 5-
HTTLPR and rs25531 variants, and their interaction; and 3) the triallelic variations 
recommended by Wendland, et al. (2006). Neither the triallelic variations, nor 
interactions between 5-HTTLPR and rs25531 were significant in predicting reactivity in 
single-gene models. Further, collinearity tolerances were exceeded when rs25531 was 
included as a unique term. Thus, this study only considered biallelic 5-HTTLPR. 
Model Variables 
Genotype data were reduced to single dichotomous variables, defined as 
homozygous “risk” allele carriers (i.e., an allele that is associated with atypical cortisol 
reactivity or risk for development of disease) compared to all “protective” allele carriers 
(heterozygous or homozygous). In preliminary analyses, heterozygous and homozygous 
carriers of “protective” alleles were indistinguishable in terms of cortisol reactivity. Thus, 
for purposes of parsimony, analyses were restricted to these dichotomous variables. 
 
Statistical Analyses 
 Preliminary analyses were conducted to examine associations among predictor 
variables and cortisol AUC components (See Tables 1 to 3; see the Appendix for all 
tables). To address multicollinearity in regression models among these variables, 
continuous predictors were standardized. All analyses were conducted using SPSS 21.0 
(IBM Corp., Armonk, NY). 
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A series of multiple regression models were used to predict each measure of 
cortisol reactivity from genes, early and recent adversity, sex, and interactions among 
these variables. Except where noted, effects of current psychopathology were not 
considered. Significant interactions were decomposed using techniques proposed by 
Aiken and West (1991). The effect of each polymorphism was first assessed separately, 
in a regression model which included all five adversity measures, sex, and their 
interactions. Predictors that exceeded collinearity tolerances (tolerance statistics <0.20) 
were removed automatically. Non-significant main effects and interactions (with p-values 
greater than 0.25) were removed from each model using backward elimination, starting 
with three-way interactions. If a higher order interaction was significant, all lower order 
interactions and main effects were retained in the single-gene model.  
All retained main effects and interactions from each of these single-gene models 
were then entered simultaneously into four regression equations, to examine the 
independent effects of each predictor and its interactions on each construct of reactivity. 
If multiple genes were predictive of a given variable in these models, gene-by-gene-by-
environment-by-sex interactions and their lower-order subcomponents were entered into 
predictive models. Again, non-significant main effects and interactions (with p-values 
greater than 0.10) were removed from final models using backward elimination, except 
when they were subcomponents of a higher-order significant interaction. All missing data 
were resolved by listwise deletion, resulting in reduced numbers of cases given 
availability of genomic data. Even though all analyses were conducted with continuous 
measures of early adversity, visual depictions are limited to dichotomous comparisons of 
“severe” and “non-severe” levels of stress for the sake of parsimony.  
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CHAPTER III 
RESULTS 
Preliminary Analyses 
 Preliminary analyses revealed significant associations among predictor and 
outcome variables. Peak levels of early childhood abuse were all positively correlated 
with one another (rs range 0.54 to 0.20, p<0.001; See Table 1); Antipathy and neglect 
showed the strongest correlation, while physical and sexual abuse were weakly 
associated. Recent exposure to a severe stressful life event or high threat difficulty were 
also associated (ɸ=0.32, p<0.001). Notably, greater childhood exposure to neglect, 
psychological abuse, and sexual abuse were significantly associated with experiencing a 
stressful life event during the last year (rs range -0.13 to -0.20,ps range <0.01 to <0.001); 
and, greater levels of all forms of early adversity were significantly associated with 
exposure to a high threat difficulty during the last year (rs range -0.24 to -0.29, p<0.001). 
 Correlations among measures of cortisol reactivity are reported in Table 1. 
Greater childhood neglect was associated with reduced cortisol Rise (r=0.12, p=0.02), 
and sexual abuse exposure was associated with greater AUCi and Rise in cortisol 
(r=0.12, p<0.05; and r=0.14, p<0.01, respectively). Exposure to a stressful life event 
during the last year was associated with decreased cortisol release across measures 
(AUCg: r=-0.13, p<0.05; AUCi: r=-0.16, p<0.01; Rise: r=-0.16, p<0.01). Exposure to a 
high threat difficulty was also associated with attenuated reactivity in response to the 
stress task (AUCi: r=-0.14, p<0.01; Rise: r=-0.14, p<0.01). 
 
37 
Sex Differences 
 Participants significantly differed in terms of cortisol reactivity with regard to sex. 
Females displayed significantly lower cortisol responses than males [AUCg: t(211.44) = 
3.20, p = .002; AUCi: t(356.60) = 2.85, p = .005; Rise: t(309.99) = 4.99, p<.001; 
Decline: t(302.92) = 4.05, p<.001; see Table 2]. All comparisons were corrected for 
inequality of variances, reflecting high variability in samples obtained from males. 
Notably, participants did not differ when t1 or t2 assays were compared, suggesting 
differences appear only during reactivity. Participants did not differ in terms of cortisol 
reactivity as a function of childhood SES or age at time of data collection. 
Only one association between sex and homozygous genetic “risk” was significant 
– more females than males carried two copies of the C allele of SNP rs25532, located in 
the serotonin transporter gene [χ2(1, N=363) = 5.53, p = .019; see Table 3]. Groups did 
not significantly differ in terms of exposure to early adversity, with the exception of 
sexual abuse, which was more severe in females (M = 4.47, SD = 1.15) than in males (M 
= 4.82, SD = 0.68; t(371)=3.613, p<.001; see Table 2).  
 
Prediction of Cortisol Reactivity 
 Sex, adversity, several candidate polymorphisms, and their interactions were 
independently predictive of variations in cortisol reactivity. Each multi-gene model 
accounted for a significant percentage of variance in reactivity – AUCg F(15,352) = 
49.53, p<0.001, Adjusted R
2
 = 0.67; AUCi F(18,346) = 4.22, p<0.001, Adjusted R
2
 = 
0.14; Rise F(10,357) = 6.12, p<0.001, Adjusted R
2
 = 0.12; Decline F(10,360) = 5.99, 
p<0.001, Adjusted R
2
 =0 .12 – even after correcting for the effects of conducting multiple 
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tests. Main effects and interactions that were significantly predictive of each cortisol 
AUC component are reported in Table 4.  
Sex 
As shown in Table 4, a significant main effect for sex was observed in all models 
predicting cortisol reactivity, controlling for all other significant genetic or environmental 
effects and interactions (ts range 3.18 – 5.57, p<0.01 or lower). A visual depiction of this 
effect, demonstrating greater cortisol release (AUCg), greater reactivity (AUCi), and 
greater variability in males, is shown in Figure 3. 
Early Adversity 
Peak measures of neglect and sexual abuse encountered before age 12 were 
significantly predictive of cortisol reactivity at age 21 in single predictor models, and 
were marginally significant in multi-gene models. As shown in Figure 4, childhood 
exposure to either form of abuse was associated with reduced cortisol reactivity to 
psychosocial stress in young adulthood. Specifically, participants displayed less of a rise 
in cortisol if exposed to higher levels of neglect from caregivers (B = 0.39, SE = 0.22, p = 
.07; see Figure 4a). Also, participants displayed more attenuated reactivity given greater 
exposure to sexual abuse (B = 0.93, SE = 0.50, p = .07; see Figure 4b). 
Recent Adversity 
Exposure to one or more severe stressful life events or one or more high threat 
difficulties during the year preceding the interview was associated with attenuated 
cortisol reactivity. As shown in Figure 5a, exposure to a severe stressful life event was 
associated with significantly attenuated Rise in participants’ cortisol compared to 
individuals not exposed to a severe event (B = -1.54, SE = 0.47, p = .001), and was 
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marginally associated with decreased overall cortisol release (B = -2.50, SE = 1.52, p = 
.10). Similarly, participants exposed to an ongoing severe difficulty displayed attenuated 
reactivity to the TSST (B = -2.74, SE = 1.31, p = 0.04). 
Genetic Polymorphisms of SERT, OPRM1, and NR3C2 
Homozygous carriers of “risk” alleles demonstrated elevated cortisol reactivity to 
the psychosocial stress task, compared to carriers of at least one copy of the protective 
allele. As shown in Figure 6, both risk polymorphisms examined in SERT (5-HTTLPR: 
B = 3.48, SE = 1.30, p = 0.06; SNP rs25532: B = 3.52, SE = 1.27, p = 0.006) predicted 
greater cortisol reactivity. Homozygous carriers of a risk allele in OPRM1 demonstrated 
greater Rise in cortisol, compared to carriers of one or more protective alleles (B = 3.83, 
SE = 1.92, p = 0.05; See Figure 7). Notably, the relationship between 5-HTTLPR 
polymorphisms and elevated reactivity was not mediated by exposure to early life stress 
or recent adversity. Also, variations in MR gene NR3C2 were not associated with cortisol 
reactivity in single-gene tests, so this variable was excluded from further analyses. 
 
Gene-Environment Interactions in Cortisol Reactivity 
 Several genes were associated with altered HPA functioning only in individuals 
exposed to early or recent adversity. These GxE interactions varied as a function of 
participant sex in many cases. 
ANKK1 x Physical Abuse x Sex 
As shown in Table 4, the three-way interaction of the ANKK1 SNP with physical 
abuse and sex was significant in the prediction of total cortisol release (AUCg). 
Decomposition of this three way interaction showed that the interaction between ANKK1 
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and physical abuse was significant for males, but it was not significant for females (B = 
1.20, SE = 9.39, p = .45). The three-way interaction in the prediction of cortisol reactivity 
(AUCi) showed a similar pattern – when decomposed by sex, the two-way interaction 
between ANKK1 and physical abuse was significant for males, but not for females (B = 
1.67, SE = 4.29, p = .70). In this sample, no female carriers of risk alleles for this gene 
were exposed to very severe physical abuse. 
Male homozygous carriers of the “risk” allele displayed greater cortisol release 
and reactivity depending on physical abuse exposure. Exposure to more severe abuse was 
associated with greater total release and elevated basal cortisol levels (AUCg physical 
abuse B = 23.64, SE = 5.66, p<.001), but also less reactivity (negative AUCi values, 
indicating a drop in cortisol over the task period); individuals who were exposed to less 
severe forms of abuse demonstrated exaggerated reactivity (AUCi physical abuse B = -
14.61, SE = 3.30, p < .001), but also greater total cortisol release compared to male 
carriers of protective alleles. 
Female homozygous carriers of the risk allele did not display a consistent pattern 
in AUCg or AUCi when physical abuse history was considered – exposure was not 
associated with variations in release or reactivity (AUCg, physical abuse B = 1.60, SE = 
9.41, p = .87; AUCi, physical abuse B = 1.24, SE = 4.27, p = .77). Similarly, male and 
female carriers of a “protective” allele did not demonstrate variations in cortisol 
functioning given abuse exposure (Males: AUCg, physical abuse B = -1.26, SE = 1.76, p 
= .48; AUCi, physical abuse B = -0.71, SE = .84, p = .40; Females: AUCg, physical 
abuse B = 0.40, SE = 1.66, p = .81; AUCi, physical abuse B = -0.42, SE = 0.81, p = .61). 
Variations in HPA responses to the TSST are displayed in Figure 8. 
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ANKK1 x Neglect x Sex 
A significant interaction between ANKK1 genotype, level of exposure to 
childhood neglect, and sex predicted variations in termination of the HPA response 
(Decline; See Table 4). Decomposition of this three way interaction showed that the 
interaction between ANKK1 and neglect was significant for females (B = 6.54, SE = 
2.00, p = 0.001), but it was not significant for males (B = -1.98, SE = 2.74, p = 0.47). 
Female “protective” allele carriers of ANKK1 demonstrated a strong relationship 
between exposure to childhood neglect and cortisol Decline – greater exposure to neglect 
was associated with attenuated cortisol release after peak (neglect B = 7.06, SE = 1.98, p 
< 0.001). Female homozygous carriers of the ANKK1 “risk” allele showed a weaker 
relationship, as reduced Decline values were marginally associated with more severe 
exposure (neglect B = 0.53, SE = 0.34, p = .12). Male “protective” allele carriers did not 
differ in terms of cortisol Decline due to neglect history (Males: neglect B = -1.80, SE = 
2.73, p=0.51). Further, males carrying two copies of the “risk” allele appeared to diverge 
in terms of Decline in a pattern opposite to that of females; however, these males showed 
no consistent relationship between severity of neglect and Decline (neglect B = 0.18, SE 
= 0.32, p = 0.58). These variations are portrayed in Figure 9. 
COMT x Physical Abuse x Sex 
The three-way interaction of the COMT SNP with physical abuse and sex was 
also significant in predicting total cortisol release (AUCg). When decomposed by sex, as 
shown in Table 4, the two-way interaction between physical abuse and COMT was 
significant for males, but not for females (B = -2.60, SE = 3.40, p = .45). In male 
homozygous carriers of the COMT “risk” allele, extent of physical abuse exposure 
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predicted cortisol release. Attenuated cortisol release was associated with more severe 
physical abuse exposure, and elevated cortisol release was associated with less severe 
exposure (physical abuse B = 6.30, SE = 2.82, p = .026). Male and female “protective” 
allele carriers did not differ in terms of cortisol release due to physical abuse history 
(Males: physical abuse B = -1.26, SE = 1.76, p=.48; Females: physical abuse B = 0.40, 
SE = 1.66, p = .81). Females carrying two copies of the “risk” allele appeared to diverge 
in terms of AUCg in a pattern opposite to that of males; however, these females showed 
no consistent relationship between severity of physical abuse and AUCg (physical abuse 
B = -2.19, SE = 2.99, p = .46). These Variations are displayed in Figure 10. 
COMT x Recent Difficulty 
A significant interaction between COMT and exposure to high threat difficulty 
was observed (See Table 4). Specifically, carriers of at least one protective allele 
demonstrated variations in reactivity depending on exposure to a recent difficulty, where 
attenuated HPA activation (lower Decline values) is marginally associated with exposure 
to a high threat difficulty during the last year (B = -1.59, SE = 1.03, p = 0.12). Carriers of 
two copies of the “risk” allele did not show a relationship between stress exposure and 
termination of HPA functioning (B = 0.65, SE = 0.61, p = 0.29). These variations are 
displayed in Figure 11. Notably, variations in COMT significantly interacted with 
exposure to recent stressful events in the prediction of total cortisol release and the 
initiation of reactivity (Rise), but these tests were not significant in multi-gene analyses. 
CRHR1 x Physical Abuse x Sex 
Three-way interactions of the CRHR1 SNP rs110402 with physical abuse and sex 
were significant in the prediction of cortisol reactivity and activation of the cortisol 
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response (Rise). When decomposed by sex, the interaction between CRHR1 and physical 
abuse was significant for males, and approached significance for females in the 
prediction of reactivity (AUCi B = -2.32, SE = 1.43, p = .10). Also, the interaction 
between CRHR1 and physical abuse predicting Rise was not significant for males, but 
was for females (B = -1.18, SE = 0.61, p = .05). As shown in Table 4, male homozygous 
carriers of the “risk” allele demonstrated attenuated reactivity given greater exposure to 
abuse. Female homozygous carriers of the CRHR risk allele displayed the opposite 
pattern to males – more severe abuse was associated with exaggerated cortisol reactivity 
(AUCi, physical abuse B = -2.74, SE = 1.21, p = .02) and cortisol Rise (B = -1.19, SE = 
0.52, p = .02). Male and female carriers of a “protective” allele did not demonstrate 
variations in overall reactivity or activation of HPA given abuse exposure (Males: AUCi, 
physical abuse B = -0.71, SE = 0.84, p = .40; Rise, physical abuse B = 0.05, SE = 0.36, p 
= .89; Females: AUCi, physical abuse B = -0.42, SE = 0.81, p = .61; Rise, physical abuse 
B = -0.01, SE = 0.36, p = .98). These variations are portrayed in Figure 12. 
ANKK1 x COMT x Physical Abuse x Sex 
The four-way interaction among these risk alleles, physical abuse, and sex was 
considered in the prediction of total cortisol release (AUCg); however, extreme 
multicollineraity between the interaction term and other lower-order predictors prevented 
analysis. Nevertheless, the two way interaction between ANKK1 x COMT, and the three 
way interactions between these genes and both sex and physical abuse were significant 
(See Table 4). In general, the effects of physical abuse on cortisol reactivity depended 
strongly on haplotype and gender. Both male and female carriers of protective alleles in 
both genes demonstrated significantly attenuated cortisol release given greater abuse 
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exposure (Males: B = 45.72, SE = 6.79, p < 0.001; Females: B = 131.37, SE = 7.49, p < 
0.001). Male and female carriers of “risk” alleles for both genes did not show consistent 
relationships between total release and physical abuse exposure (Males: B = 1.31, SE = 
1.06, p = 0.22; Females: B = 0.13, SE = 1.13, p = 0.91). Carriers of one risk allele or the 
other showed relationships comparable to Sex-by-GxE interactions previously 
interpreted. 
ANKK1 x CRHR1 x Physical Abuse x Sex 
The four-way interaction among these risk alleles, physical abuse, and sex was 
also considered in the prediction of AUCi. Extreme multicollineraity between the 
interaction term and other lower-order predictors prevented analysis. Lower-order 
interaction terms were not significant, except those already reported. 
Effects of CRHR1 SNP rs1876831 
A significant three-way interaction was observed among CRHR1 SNP rs1876831, 
childhood neglect, and sex predicting termination of HPA functioning (B = 1.35, SE = 
0.61, p = 0.03). However, this interaction was not significant in multi-gene analyses.  
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CHAPTER IV 
DISCUSSION 
 The present study was developed to examine the interactive effects of sex, early 
and recent adversity, and polymorphisms associated with variations in the human stress 
response on cortisol reactivity. In most cases, the primary hypotheses of this study were 
supported. Overall, young adult females displayed reduced cortisol reactivity to the TSST 
compared to males. Individuals exposed to greater levels of early adversity or recent life 
stress generally displayed attenuated reactivity, while homozygous carriers of risk alleles 
in SERT and OPRM1 displayed elevated reactivity. Exposure to physical abuse 
interacted with three polymorphisms – SNPs in COMT and ANKK1, and SNP rs110402 
in CRHR1 – and the nature of these interactions depended on sex. In general, physically 
abused males who carried risk alleles displayed attenuated reactivity, while females 
displayed elevated reactivity under the same circumstances. Individuals who carry alleles 
identified by previous studies or implicated by the corpus of research to be at-risk for 
cortisol dysregulation have shown that they are indeed demonstrating the varied effects of 
allostatic load when exposed to stressors (i.e., hypo- or hyperreactivity). 
To date, this is the first study to measure the multiple independent effects of GxE 
interactions simultaneously. The pattern of significance observed in these interactions 
informs a complex developmental model of cortisol dysregulation. Partial replications 
and non-replications of previous studies may be due to random variations in study 
samples, or may occur because GxE interactions were previously examined in a statistical 
(and, by proxy, psychobiological) vacuum. Gene-by-GxE interactions were also 
evaluated, and explain more variability in reactivity than single-gene models. 
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Effect of Participant Sex 
 Differences attributable to participant sex have been demonstrated in the current 
study, consistent with the body of literature suggesting human females release less 
cortisol in response to psychosocial stress than males (e.g., Kudielka and Kirschbaum, 
2005). It is conceivable that the effect of sex observed in these studies could have been 
due to increased exposure to early adversity, which is also associated with attenuated 
reactivity. In the present study, females reported significantly more exposure to sexual 
abuse than males, and this exposure might explain their attenuated reactivity as adults. 
However, this study evaluated the effect of sexual abuse exposure, sex, and their 
interaction, and found that both sexual abuse exposure and participant sex were 
independently predictive of attenuated reactivity. Thus, divergent biological responses 
and coping mechanisms (but not differential exposure) likely explain sex differences. 
 
Effect of Exposure to Adversity 
 Regardless of sex, individuals who were exposed to both distal and proximal 
forms of adversity exhibited attenuated reactivity compared to individuals exposed to 
lesser or no adversity. This finding is consistent with research associating childhood 
exposure to neglect or sexual abuse with reduced cortisol reactivity in adolescence or 
adulthood (e.g., Lovallo et al., 2012). The association between recent life stress and 
reactivity is consistent with some research (e.g., Armbruster et al., 2012), but other 
studies often demonstrate effects of recent life stress given genetic vulnerabilities (e.g., 
Alexander et al., 2009). Taken together, these findings reinforce the idea that repeated or 
ongoing exposure to environmental stressors can independently alter cortisol functioning 
47 
during any period in life, as opposed to effects being limited to exposure during early 
childhood or to individuals with “risk” alleles. In all cases, participants were exposed to 
highly-threatening experiences, and responded to subsequent stressors with reduced 
reactivity (i.e., demonstrated effects of allostatic load). 
 
Effects of Genetic Vulnerabilities 
 Several genetic vulnerabilities identified in previous research demonstrated 
effects on cortisol reactivity. As hypothesized, homozygous carriers of “risk” 
polymorphisms in SERT (5-HTTLPR, and SNP rs25532) and OPRM1 (rs1799971) 
demonstrated elevated cortisol reactivity compared to “protective” allele carriers. 
The finding regarding 5-HTTLPR is consistent with a recent meta-analysis of 
studies on cortisol reactivity and this polymorphism, which found a small effect for 
homozygous carriers of the short allele on increased reactivity (Miller et al., 2013). The 
current study also verifies the independence of this effect, as opposed to inconsistent 
interactive effects reported by Mueller et al. (2011), Alexander et al. (2009), and others. 
Both “risk” alleles and environmental stressors may be risk factors for the onset of these 
disorders, but the effects of stressors and genotype may not depend on one another. The 
current study also tested both the biallelic and triallelic variations in 5-HTTLPR, and 
found no significant results associated with the latter. 
 The reported association between the “risk” allele in SERT SNP rs25532 and 
reactivity is new, and may reflect the overall importance of SERT in the regulation of the 
HPA system. Any genetic variation that alters the expression or functioning of this gene 
should be considered in future research on cortisol reactivity. 
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 The observed effect of OPRM1 vulnerability as a promoter of elevated HPA 
activation (i.e., Rise) is generally consistent with a study by Chong et al. (2006), who 
found differences only in peak cortisol release following the TSST. One would expect 
genes that alter termination of HPA activity to predict Decline, but both studies show 
effects for activation of HPA. The current data include only five individuals with this 
vulnerability; thus, high variability in Decline may have prevented observation of a 
significant effect. Further study is needed to examine the effects of this polymorphism. 
No Effect of NR3C2 
In contrast to previous studies of participants in the TSST, the current study did 
not find global or interactive effects associated with MR polymorphism SNP rs5522 in 
gene NR3C2. The vulnerability, previously associated with exaggerated cortisol 
reactivity, did not discriminate among typical or dysregulated responses, and was the 
only predictor selected before initiation of the study that did not produce a statistically 
significant result in single-gene models. Given the associations of MRs with basal 
activity rather than reactivity, the finding is not surprising. deKloet (2008) notes that 
variations in this gene are rare, but not to the degree observed in the current data; only 
five individuals carried two copies of the risk allele. Secondary tests using heterozygous 
risk allele carriers and multiple genotype groups were also not successful. A larger 
sample of at-risk individuals will be required to measure the effects of this gene. 
 
Gene-Environment Interactions 
 Several genetic and environmental risk factors were found to interact in predicting 
dysregulation, and these effects were moderated by sex. Specifically, males who carry 
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two copies of “risk” alleles in three genes – SNP rs110402 in CRHR1, and SNPs in 
COMT and ANKK1 – displayed attenuated reactivity given greater exposure to 
childhood physical abuse, while females display elevated reactivity given the same 
circumstances. Males and females were exposed nearly equally to physical abuse before 
age 12, but their responses to psychosocial stress as adults diverged significantly. These 
GxE-by-sex effects could be caused by divergence in adaptation to physical abuse in 
childhood, by differences in cognitive or emotional processing of the stressor (i.e., males 
may be more ego-threatened by both physical violence and the TSST, compared to 
females), or they could manifest as extensions of the basal sex differences in stress 
reactivity found in all participants. Differential coping, rather than differential exposure, 
explains observed sex differences in GxE interactions. 
CRHR1 Interactions 
 Results of the current study suggest that CRHR1 SNP rs110402 is the strongest 
indicator of phenotypic risk, as its associations with reactivity explained more variability 
than those of SNP rs1876831 in multi-gene analyses. Current findings bear some 
resemblance to those of previous research on CRHR1, but are very different upon close 
inspection. Gene-by-abuse-by-sex interactions reported by Heim et al. (2009) and in this 
study differ by genotype, such that phenotypic expressions of reactivity are opposites. 
Heim et al. note that long term changes in CRH functioning are only associated with 
physical and not sexual abuse (supported by the current study), but also suggest and do 
not test the idea that differential exposure explains the sex difference (not supported by 
the current study). On the other hand, the at-risk sample in the Tyrka et al. study was over 
70% female, and the pattern of response reported more closely resembles that of females 
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in the present study (where maltreated homozygous GG allele carriers displayed elevated 
reactivity), albeit involving a different SNP. Although the present findings are interesting, 
they are also difficult to reconcile with extant literature on GxE involving CRHR1.  
COMT Interactions 
 The divergent effects of sex on GxE in reactivity are not limited to a single gene, 
but also independently involve other genes. The effects of COMT on reactivity have 
previously been reported as main effects, where carriers of risk alleles demonstrate 
elevated reactivity, and this finding was not supported in the current study. Instead, the 
current study reports novel GxE interactions that are moderated by sex – male carriers of 
risk alleles demonstrate attenuated reactivity given exposure to greater physical abuse, 
and females display elevated reactivity given greater exposure and genetic risk.  
COMT also interacts with recent stressors in the prediction of cortisol reactivity. 
Homozygous carriers of risk alleles who were not exposed to recent high threat 
difficulties demonstrate an effect similar to that reported by previous studies – an 
elevated response. In comparison, those carriers exposed to a recent difficulty 
demonstrate reduced responses (already associated with attenuated reactivity). Carriers of 
protective alleles demonstrate comparable (i.e., normal) reactivity, even if they were 
exposed to a recent difficulty. The parallel results in the current study suggest that the 
genetic vulnerability within COMT affects HPA functioning over the entire life course, 
but these effects may depend on exposure to certain forms of abuse (physical abuse in 
males, ongoing difficulties in all individuals). These effects also depend on sex, as males 
and females show different responses to physical abuse and acute psychosocial stress. 
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ANKK1 Interactions 
The finding that variations in ANKK1 are associated with cortisol reactivity has 
not been previously reported. Homozygous males carriers of the genetic vulnerability 
displayed dramatically elevated reactivity – on the order of 2-3x greater than most 
participants. Males with this predisposition and a history of severe physical abuse 
displayed low resting cortisol, but were the most “activated” by the TSST (i.e., AUCi 
values were greatest); males exposed to less severe physical abuse displayed elevated 
reactivity throughout the TSST. Females did not display a consistent pattern, but this was 
due to limited exposure to severe physical abuse in female risk allele carriers.  
Given that male risk allele carriers displayed such unusual reactivity, in the 
absence of firm evidence for functional variation in existing literature, one must postulate 
reasons for these findings. These individuals may have high basal cortisol levels due to a 
disorder associated with dopaminergic variation (such as substance abuse), or ANKK1 
has some effect on HPA functioning outside of the expected alterations of dopaminergic 
functioning. Exposure to uncontrollable stress promotes dopamine release, but the 
indirect actions of dopamine on cortisol reactivity are less extensively tested. 
Within the scope of this study, some of these issues can be addressed. ANKK1 
genotype was not significantly associated with any current SUD diagnosis (alcohol, 
cannabis, nicotine, opiates, or stimulants), any mood disorder diagnosis, or any anxiety 
disorder diagnosis. Further, inclusion of variables representing current MDD or SUD 
diagnoses did not alter observed relationships among sex, early abuse exposure, and 
ANKK1 genotype in single-gene analyses. Future research will be required not only to 
replicate this effect, but also to elucidate the mechanisms behind it. 
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Consistent Systemic Effects on HPA Functioning 
 Most of the proposed hypotheses were supported by the results of the current 
study, patterned in ways that inform models of cortisol dysregulation over the 
developmental course. Global effects on reactivity were found involving genes that 
regulate the termination of HPA activity, while genes that regulate activation of the HPA 
system demonstrated interactive effects with stress exposure and sex. Greater stress 
exposure is also associated with attenuated reactivity over the life course. 
Both CRHR1 and COMT genetic vulnerabilities likely alter the HPA system 
through prolonged activation. COMT degrades catecholamines such as norepinephrine, 
which activates the HPA axis. The genetic vulnerability in COMT is associated with a 
four-fold decrease in production of the enzyme, which would lead to the presence of 
norepinephrine for longer periods of time. CRH acts as a relay in the HPA axis, 
stimulating the release of ACTH; yet, the genetic vulnerability in CRHR1 is 
inconsistently related to reactivity. In both cases, neuroendocrine mechanisms that initiate 
and maintain HPA activity interact with sex and early life stress, suggesting that these 
systems change in response to environmental experiences that occur during critical 
periods. Given the similarity of findings, it is possible that variations in ANKK1 also 
effect change during early critical periods, altering activation of the HPA system. 
The divergent patterns of these developmental changes (with vulnerable males 
displaying attenuated reactivity, and vulnerable females displaying elevated reactivity) 
counter the typical models of functioning in this population, where males displayed 
greater reactivity than females. In individuals who carry “risk” alleles that alter 
activation, the phenotypic manifestation of that “risk” may be HPA functioning that is the 
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opposite of what would develop typically. These patterns of response may diverge over 
time, as the child is exposed to repeated instances of physical abuse.  
 The main effects of SERT and OPRM1 polymorphisms – resulting in elevated 
reactivity in carriers of “risk” alleles – likely alter HPA functioning through termination 
of the response. Although serotonin is also implicated in its activation, the inability to 
quickly “turn-off” the HPA response by serotonergic feedback mechanisms likely 
contributes to elevated measures of reactivity. In both cases, termination of HPA appears 
to be genetically determined, rather than being affected by sex or adversity. Epigenetic 
effects (e.g., altered SERT gene expression given repeated glucocorticoid influx) likely 
shape the actions of HPA termination, suggesting an indirect role for stress exposure. 
 
Risk versus Resilience 
 This study has perpetuated a basic idea in studies of phenotypic variations in 
disease processes – one gene is “good,” and the other is “bad.” This notion of risk, and 
its complement resilience, is related to broadly-defined cortisol dysregulation in the 
current study, where risk is either elevated or attenuated cortisol release. Experientially, 
elevated short term cortisol release is the “ideal” response, inhibiting key physiological 
functions while the individual copes with the stressor. Yet, elevated reactivity to 
laboratory-controlled psychosocial stress is considered a maladaptive outcome in some 
studies, so the construct is labelled “risky” by virtue of being stress-reactive and 
associated with cardiovascular diseases. Attenuated reactivity is also considered a 
maladaptive response, since it does not allow for effective mobilization of resources, and 
leaves the individual vulnerable to autoimmune diseases. 
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 Concepts like risk and resilience should be defined relative to the context of the 
individual and a specific disease process. This study has addressed this issue by 
enumerating as much of the individual’s context (biologically and environmentally) as is 
practical in longitudinal social science research. In doing so, this study has demonstrated 
that genetic risk may contribute to very different functional outcomes depending on other 
factors (e.g., participant sex, stress exposure). In turn, these outcomes will only lead to 
further risk for or resilience from disease given individuals’ biological and environmental 
predispositions. Future studies of risk and resilience for psychological or physiological 
disorders must consider a wide variety of contextual information. Otherwise, 
mathematical models of disease processes will lack face validity, and our understanding 
of pathology will be diminished. 
 
Strengths 
This study considers the interactive effects of genes, adversity, and sex, with 
regard to other independent effects on cortisol reactivity. Although this method tests the 
robustness of multiple regression, it also allows for consideration of how effects may be 
shaped or negated by other effects. Several single-factor findings were significant, only to 
be called non-significant in multi-gene analyses. This suggests that future examinations 
of stress reactivity should consider sex, life stress, and other key genes when examining 
the effects of a given gene or stressor. Overall, one must question the utility of single-
gene studies, which are advantageous in terms of hypothesis testing, but disadvantageous 
in terms of the applicability of results. The present study is not powerful enough to show 
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very weak main effects, but it also has the predictive resolution necessary to examine 
GxE effects carefully and in great detail. 
The study verifies many previously reported global effects on cortisol reactivity 
(e.g., sexual abuse is associated with attenuation of HPA activity; 5-HTTLPR is 
associated with slight elevation), and embellishes on some inconsistent findings (e.g., 
CRHR1 interacts with sex and physical abuse). Novel GxE-by-Sex interactions robustly 
elucidate a system-level model of cortisol reactivity, shaped over time by genetically-
moderated developmental experiences. These effects are reported on a racially-
homogenous cohort of young adults, controlling by design for variations in germ-line and 
developmental status that may alter cortisol secretion. The study utilized salivary cortisol 
samples from 373 individuals, making it one of the largest TSST samples collected. 
Although measures of genetic polymorphisms and salivary cortisol are consistent 
across most studies, measures of life stress utilized in other studies are of varying quality, 
to the detriment of the field in general (Monroe and Reid, 2008). The present study 
utilized the gold-standards in life stress assessment – the LEDS and CECA – that provide 
more accurate information in greater detail than any self-report measure of life stress. 
GxE interactions reported in this study should be considered more reliable measures of 
effects, since they are based on these high-resolution stress measurement interviews. 
 
Limitations 
 The attention-to-detail required for a study like this also contributes to a number 
of limitations. The sample size in the current study is large compared to other studies of 
cortisol reactivity, but small compared to other studies assessing the effects of genes on 
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pathology. Oftentimes, these studies aggregate results from a variety of samples or 
examine the entire genome, and measure the general contributions of genes to variations 
in pathology. Yet, adding sample size does not necessarily lead to more precise findings. 
Indeed, the myopia that affects smaller studies of GxE effects (where objects examined 
are clear, but decontextualized) is not corrected in large studies, which blur effects of 
genes by poorly aggregating outcome measures. 
 The method employed by this study was to choose genes that “tag” a particular 
neuroendocrine system associated with HPA activity. This limited examination of eight 
genes – chosen for their predictive power, and for the sake of efficiency – means that 
gene-specific knowledge gained from this study is limited. Further, genes that were 
examined were reduced to dichotomous variables. This prevented analysis of dose-
response relationships for genes, where more of a “risk-associated” or “protective” allele 
is associated with greater or lesser variation. Studies that examine heterozygosity are 
highly inconsistent, suggesting that establishment of the absolute “risk” or “protection” 
conferred by a gene should be a priority in research. 
Many of the GxE effects reported in the current study are novel, and must be 
verified on additional samples. Specifically, the significant amount of variability 
accounted for by GxE effects involving ANKK1 is suspect, and these effects must be 
replicated. Yet, other findings show a consistent pattern and fit with other known GxE 
observations. Further, this sample is primarily representative of young adults who are of 
European-American origin, so results will need to be replicated in individuals from other 
racial groups. While the relative homogeny of this sample allowed for easier examination 
of genetic effects, GxE interactions describing a subset of humans are of limited utility. 
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With the exception of the inclusion of diagnostic covariates in some preliminary 
analyses, this study ignored an individual’s history of psycho- or physiopathology in 
regression models of cortisol reactivity. Many forms of pathology are associated with 
variations in reactivity – depression, anxiety, and some forms of substance abuse are 
associated with elevated cortisol release; PTSD and other forms of substance abuse are 
associated with attenuated cortisol release. This study presumed that these pathologies are 
manifestations of the underlying processes being assessed. Thus, it is unclear whether the 
development of pathology contributes to dysregulation, or vice versa. The processes 
underlying dysregulation and disease are likely interactive, and would need to be 
assessed as they develop. Future studies should examine the developmental progression 
of cortisol reactivity given differential exposure to stress and genetic risk, and also 
examine the parallel progression of associated diseases to establish causality. 
 
Implications for Prevention and Treatment 
 This study has wide implications on future efforts to prevent and treat a variety of 
psychological and physiological diseases. Cortisol reactivity is an endophenotype of 
those diseases, and may represent a useful biomarker for assessing disease risk, or 
projecting or tracking therapeutic change. For example, multiple SNPs in CRHR1 are 
associated with irritable bowel syndrome (IBS) symptom subtypes (e.g., Sato et al., 
2012), and treatments are often focused on those symptom subtypes. IBS is a chronic 
functional gastrointestinal disorder characterized by bowel inflammation; strong 
associations with depression and anxiety suggest that neuroendocrine dysregulation may 
underlie both disorders. If certain SNPs modulate HPA functioning through exposure to 
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psychosocial stress, and responses to those stressors vary by sex, then both prevalence of 
IBS subtypes and their treatments could be related to GxE-by-Sex processes reported 
herein. For example, abuse history may predict poor IBS treatment outcomes in female 
carriers of CRHR1 risk alleles. 
 Cortisol reactivity may, in itself, represent a risk factor for poor outcomes of 
treatment efforts. Variations in HPA functioning are likely associated with altered 
functioning of drugs used to treat a variety of disorders (e.g., selective serotonin reuptake 
inhibitors), but HPA activity also affects responses to psychosocial interventions. In one 
study, dropping out of a residential treatment program for SUDs was associated with 
higher salivary cortisol responses to computer-administered psychological stress tasks 
(Daughters, Richards, Gorka, and Sinha, 2009). In another study, attenuated cortisol 
release was associated with alcohol administration to heavy drinkers, but elevated 
reactivity in light drinkers (King, Munisamy, de Wit, and Lin, 2006), suggesting those 
demonstrating attenuated reactivity may be more difficult to treat. Given that cortisol 
reactivity to psychosocial stress is affected by sex-moderated GxE effects, future 
examinations of the efficacy of these and other psychosocial treatments should include 
assessments of patients’ HPA functioning. 
 
Future Directions 
Future studies on cortisol reactivity should account for well-established effects 
when validating novel GxE effects. Like any study, a larger sample size could be used to 
identify global and interactive risk factors for hypo- or hyperreactivity more reliably, and 
to identify more nuanced patterns of functioning associated with genetic vulnerability. In 
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addition to examining biallelic variations, future studies should also examine haplotypes 
– common combinations of genetic polymorphisms that may be associated with negative 
outcomes or risk endophenotypes. 
Also, the associations between genes and environmental risk factors on reactivity 
should be examined relative to diurnal variation. This construct of cortisol functioning 
may be associated with different disease processes than reactivity – it may represent an 
endophenotype of a subset of disorders, or may represent a useful indicator for measuring 
symptomatic change during an intervention. Also, the connections between diurnal 
variation and reactivity need to be established more clearly. 
Conclusion 
Variations in cortisol reactivity are associated with multiple independent and 
interactive factors, including sex, genetic polymorphisms, and exposure to early or recent 
adversity. The impact of ongoing stress exposure is clear when examining changes within 
a person, but obfuscated when examining changes across people. Thus, cortisol reactivity 
and associated diseases processes should be evaluated with regard to the developmental 
and neurobiological idiosyncrasies of the individual. Our understanding of the 
transactional processes that underlie diseases would benefit from this contextualized 
approach to clinical research.  
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Figure 1. Typical cortisol functioning, and two forms of dysregulation caused by 
prolonged stress exposure (i.e., allostatic load). Hyperreactivity is characterized by 
elevated cortisol levels throughout exposure to stressors. Hyporeactivity is characterized 
by a blunted response to stress exposure. 
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Figure 2. AUC components of cortisol reactivity. AUCg measures total cortisol release. 
AUCi measures cortisol released during task, relative to baseline (i.e., reactivity). Rise 
measures the activation of HPA activity. Decline measures the termination of HPA 
activity. 
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Figure 3. Mean cortisol concentrations over time by sex.   
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4a. Neglect 
  
 
4b. Sexual Abuse 
  
Figure 4. Mean cortisol concentrations over time by exposure to childhood abuse.  
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5a. SLE during last year. 
 
 
5b. High threat difficulty during last year. 
  
Figure 5. Mean cortisol concentrations over time by exposure to recent adversity.  
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6a. 5HTTLPR (VNTR). 
 
 
6b. SERT rs25532. 
 
Figure 6. Mean cortisol concentrations over time by serotonin transporter genotypes.  
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Figure 7. Mean cortisol concentrations over time by OPRM1 genotype. 
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8a. Males. 
 
 
8b. Females. 
 
Figure 8. Mean cortisol concentrations over time by ANKK1 genotype and physical 
abuse history.  
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9a. Males. 
  
 
9b. Females. 
 
Figure 9. Mean cortisol concentrations over time by ANKK1 genotype and neglect 
history.  
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10a. Males. 
 
 
10b. Females. 
 
Figure 10. Mean cortisol concentrations over time by COMT genotype and physical 
abuse history.  
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Figure 11. Mean cortisol concentrations over time by COMT genotype and recent high 
threat difficulty. 
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12a. Males. 
 
 
12b. Females. 
 
Figure 12. Mean cortisol concentrations over time by CRHR1 genotype and physical 
abuse history.  
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Table 1. Associations between Measures of Adversity and Cortisol Reactivity. 
Variable 1 2 3 4 5 6 7 8 9 10 
Early Adversity    
1. Antipathy --          
2. Neglect .54*** --         
3. Psychological Abuse .42*** .45*** --        
4. Physical Abuse .36*** .29*** .38*** --       
5. Sexual Abuse .26*** .24*** .23*** .20*** --      
Recent Adversity           
6. Severe SLE in last 
year 
-.50 -.20*** -.11* -.09 -.13* --     
7. High Threat 
Difficulty 
-.27*** -.27*** -.29*** -.25*** -.24*** .32*** --    
Cortisol Reactivity    
8. AUCg .03 .07 .07 .05 .08 -.09 -.07 --   
9. AUCi .03 .04 .05 -.05 .12* -.09 -.10 -.15** --  
10. Rise .07 .12* .08 .02 .14** -.18*** -.11* .62*** .51*** -- 
11. Decline .03 .10 .07 .01 .04 -.10 -.03 .81*** -.14** .57*** 
 
Notes: Associations between continuous variables (CECA, Cortisol) are Pearson’s r; associations between these variables and 
Recent Adversity measures (dichotomous) are Spearman’s r; association between Recent Adversity variables is a phi-
coefficient. 
*p<.05   **p<.01   ***p<.001 
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Table 2. Cortisol Reactivity Measures and Adversity Summary Scores by Sex. 
Cortisol Reactivity 
Mean (SD) 
Males 
(n = 189) 
Females 
(n = 184) 
AUCg 19.16 (28.78)** 12.25 (7.11)** 
AUCi 4.12 (10.48)** 1.33 (8.32)** 
Rise 4.06 (4.73)*** 2.05 (2.85)*** 
Decline 3.86 (5.42)*** 2.00 (3.14)*** 
CECA Domain 
Mean (SD) 
 
Antipathy 4.43 (1.08) 4.33 (1.20) 
Neglect 4.47 (1.10) 4.34 (1.18) 
Psychological Abuse  4.62 (0.88) 4.60 (0.90) 
Physical Abuse 3.92 (1.00) 4.07 (1.05) 
Sexual Abuse 4.82 (0.68)*** 4.47 (1.15)*** 
LEDS Domain 
n (%) Yes during last 
year 
  
Severe Stressful Life 
Event 
43 (22.8%) 50 (27.2%) 
High Threat Difficulty 44 (23.3%) 51 (27.7%) 
 
Notes: Lower CECA domain scores indicate more severe levels of abuse. 
Groups were compared using Student’s t-test. 
**p<.01   ***p<.001 
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Table 3. Distributions of Sample Participants by Genotype and Sex. 
Genetic Polymorphism 
(SNP or VNTR) 
(N = 373) 
Sex: 
Males 
(n = 189) 
Females 
(n = 184) 
5-HTTLPR (VNTR) Homozygous Risk 39 (10.5%) 29 (7.8%) 
 Protective 147 (39.7%) 155 (41.9%) 
ANKK1 (rs1800497) Homozygous Risk 10 (2.7%) 6 (1.6%) 
 Protective 178 (47.8%) 178 (47.8%) 
COMT (rs4680) Homozygous Risk 52 (14.0%) 50 (13.5%) 
 Protective 136 (36.7%) 133 (35.8%) 
CRHR1 (rs110402) Homozygous Risk 56 (15.1%) 61 (16.4%) 
 Protective 132 (35.6%) 122 (32.9%) 
CRHR1 (rs1876831) Homozygous Risk 115 (31.0%) 121 (32.6%) 
 Protective 73 (19.7%) 62 (16.7%) 
NR3C2 (rs5522) Homozygous Risk 5 (1.3%) 3 (0.8%) 
 Protective 183 (49.3%) 180 (48.5%) 
OPRM1 (rs1799971) Homozygous Risk 3 (0.8%) 2 (0.5%) 
 Protective 185 (49.9%) 181 (48.8%) 
SERT (rs25532) Homozygous Risk 121 (33.0%)* 138 (37.6%)* 
 Protective 65 (17.7%)* 43 (11.7%)* 
 
Notes: “Homozygous Risk” refers to individuals who are homozygous carriers of alleles 
associated with extreme variations in CR. “Protective” refers to individuals who are 
carriers of at least one copy of an allele not associated with abnormal CR (often a major 
allele). Totals vary by gene due to missing data. Groups were compared using χ2 tests. 
*p<.05 
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Table 4. Prediction of Cortisol Reactivity from Sex, Adversity, Polymorphisms, and Their Interactions. 
Cortisol Reactivity: AUCg AUCi Rise Decline 
Predictors: B SE t B SE t B SE t B SE t 
Sex 5.14 1.55 3.32*** 3.76 1.19 3.18** 2.69 0.48 5.62*** 1.42 0.46 3.13** 
Early Adversity:             
Neglect -- -- -- -- -- -- 0.39 0.22 1.80† 0.18 0.32 0.55 
Physical Abuse 1.31 1.06 1.23 -0.60 0.82 -0.73 0.14 0.34 0.41 -- -- -- 
Sexual Abuse -- -- -- 0.93 .50 1.85† -- -- -- -- -- -- 
Recent Adversity:             
SLE during last year -2.50 1.52 -1.64† -- -- -- -1.49 0.47 -3.16** -- -- -- 
High Threat Difficulty in last year -- -- -- -2.74 1.31 -2.08* -- -- -- 0.65 0.61 1.06 
Polymorphisms:             
5HTTLPR (VNTR) -- -- -- 3.48 1.30 3.14* -- -- -- -- -- -- 
ANKK1 (rs1800497) -2.90 8.87 -0.33 -1.42 3.84 -0.37 -- -- -- -0.77 1.92 -0.40 
COMT (rs4680) 2.94 2.25 1.31 0.61 1.23 0.05 -- -- -- 1.09 0.58 1.89† 
CRHR1 (rs110402) -- -- -- 1.14 1.42 0.80 1.68 0.60 2.79** -- -- -- 
OPRM1 (rs1799971) -- -- -- -- -- -- 3.90 1.92 2.04* -- -- -- 
SERT (rs25532) -- -- -- 3.52 1.27 2.78** -- -- -- -- -- -- 
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Table 4. (Continued) 
Cortisol Reactivity: AUCg AUCi Rise Decline 
Interactions: B SE t B SE t B SE t B SE t 
Neglect x Sex -- -- -- -- -- -- -- -- -- 0.35 0.46 0.77 
Physical Abuse x Sex -1.19 1.56 -0.77 -0.42 1.17 -0.36 -0.11 0.49 -0.22 -- -- -- 
ANKK1 x Sex 1.59 9.97 0.16 -7.48 4.92 -1.52 -- -- -- 6.07 2.40 2.53** 
COMT x Sex -2.67 3.07 -0.87 -- -- -- -- -- -- -- -- -- 
CRHR1 x Sex -- -- -- -1.99 2.05 -.97 -2.41 0.87 -2.78** -- -- -- 
ANKK1 x Neglect -- -- -- -- -- -- -- -- -- -1.98 2.74 -0.72 
ANKK1 x Physical Abuse -64.64 7.52 -8.59*** 1.95 4.29 0.45 -- -- -- -- -- -- 
COMT x Physical Abuse -6.52 2.20 -2.97** -- -- -- -- -- -- -- -- -- 
CRHR1 x Physical Abuse -- -- -- -2.47 1.43 -1.72* -1.32 0.61 -2.18* -- -- -- 
COMT x Recent Difficulty -- -- -- 4.13 2.50 1.65† -- -- -- -2.24 1.18 -1.90* 
ANKK1 x COMT 11.17 11.14 1.00 -- -- -- -- -- --    
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Table 4. (Continued) 
Cortisol Reactivity: AUCg AUCi Rise Decline 
Interactions: B SE t B SE t B SE t B SE t 
ANKK1 x Neglect x Sex -- -- -- -- -- -- -- -- -- 8.51 3.39 2.51** 
ANKK1 x Physical Abuse 
x Sex 
78.48 7.94 9.88*** -15.90 5.46 -2.91** -- -- -- -- -- -- 
COMT x Physical Abuse 
x Sex 
8.39 3.03 2.77** --  -- -- -- -- -- -- -- 
CRHR1 x Physical Abuse 
x Sex 
-- -- -- 5.45 2.07 2.63** 1.99 0.87 2.30* -- -- -- 
ANKK1 x COMT x Sex 166.38 15.03 11.07***          
ANKK1 x COMT x 
Physical Abuse 
115.57 7.96 14.52***          
 
Notes: Males are coded as 0; homozygous carriers of risk alleles are coded as 0. Coefficients are missing for variables not used 
in final regression equation to predict a cortisol variable. 
† p<.10   *p<.05   **p<.01   ***p<.001 
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